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DEDICATION				 To	my	parents,	for	everything.	
	
A	Psalm	of	life	-Henry	Wadsworth	Longfellow		 “Tell	me	not,	in	mournful	numbers,				“Life	is	but	an	empty	dream!”	For	the	soul	is	dead	that	slumbers,				And	things	are	not	what	they	seem.					Life	is	real!	Life	is	earnest!				And	the	grave	is	not	its	goal;	“Dust	thou	art,	to	dust	returnest,"				Was	not	spoken	of	the	soul.		Not	enjoyment,	and	not	sorrow,				Is	our	destined	end	or	way;	But	to	act,	that	each	to-morrow				Finds	us	farther	than	to-day.					Art	is	long,	and	Time	is	fleeting,				And	our	hearts,	though	stout	and	brave,	Still,	like	muffled	drums,	are	beating				Funeral	marches	to	the	grave.					In	the	world’s	broad	field	of	battle,				In	the	bivouac	of	Life,	Be	not	like	dumb,	driven	cattle!				Be	a	hero	in	the	strife!					Trust	no	Future,	howe’er	pleasant!				Let	the	dead	Past	bury	its	dead!	Act,--act	in	the	living	Present!				Heart	within,	and	God	o’erhead!					Lives	of	great	men	all	remind	us				We	can	make	our	lives	sublime,	And,	departing,	leave	behind	us				Footprints	on	the	sands	of	time;					Footprints,	that	perhaps	another,				Sailing	o’er	life’s	solemn	main,	A	forlorn	and	shipwrecked	brother,				Seeing,	shall	take	heart	again.					Let	us,	then,	be	up	and	doing,				With	a	heart	for	any	fate;	Still	achieving,	still	pursuing				Learn	to	labor	and	to	wait.”					
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ABSTRACT	OF	THE	DISSERTATION		Cytochrome	P450:	Nature’s	Aircraft	Carrier		By		Alec	Hoffman	Follmer		Doctor	of	Philosophy	in	Chemistry			University	of	California,	Irvine,	2019		Professor	Thomas	L.	Poulos,	Chair			Cytochromes	 P450	 are	 heme-containing	 enzymes	 that	 utilize	 O2	 for	 C–H	 bond	activation	and	play	essential	roles	in	drug	detoxification	and	biosynthesis	of	steroids	and	a	variety	of	natural	products.	A	number	of	P450s	now	have	been	shown	to	adopt	both	an	open	and	closed	conformational	state.	In	the	open	state,	the	active	site	is	solvent	exposed.	Upon	substrate	binding,	the	P450	shifts	to	the	closed	state	and	sequesters	the	active	site	from	bulk	solvent.	Since	its	discovery,	cytochrome	P450cam	has	served	as	a	paradigm	for	mechanistic	and	 structure-function	 studies.	 Over	 many	 years	 of	 investigation,	 a	 wealth	 of	 data	 has	suggested	that	P450cam	may	possess	two	camphor	binding	sites,	the	active	site	pocket	and	an	 additional	 site	 that	 shifts	 P450cam	 toward	 the	 open	 state.	 However,	 location	 of	 this	secondary	 site	 was	 never	 determined.	 Here,	 molecular	 dynamics	 simulations	 were	performed	that	revealed	the	location	of	a	secondary	site	on	the	surface	of	P450cam.	Binding	to	this	allosteric	site	assists	in	the	opening	of	both	the	primary	and	new	secondary	active	site	access	 channel.	 Related	 to	 these	 observations	 is	 the	 recent	 finding	 that	 the	 binding	 of	
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P450cam’s	redox	partner,	Pdx,	favors	the	open	conformation.	This	shift	towards	the	open	state	has	led	to	the	hypothesis	that	in	order	to	provide	the	proton	relay	network	required	for	O2	activation,	P450cam	must	undergo	a	structural	rearrangement	from	the	closed	form.	Here,	we	present	the	X-ray	crystal	structure	of	P450cam	complexed	with	its	redox	partner,	Pdx,	substrate,	and	cyanide	as	a	mimic	of	a	critical	intermediate	of	the	catalytic	cycle,	the	“oxy-complex”.	The	structure	of	P450cam	undergoes	ordered	changes	proposed	originally	by	NMR	but	never	observed	crystallographically.	These	changes	provide	a	channel	for	water	entry	 and	 product	 egress	 in	 agreement	with	 the	 channel	 formation	 hypothesized	 by	 our	simulations.	 These	 redox	 partner	 interactions	 studies	 are	 extended	 to	 a	 homologue	 of	P450cam,	P450terp,	which	exhibits	a	less	stringent	selectivity	for	its	native	redox	partner	Tdx,	whose	binding	may	still	 induce	a	conformational	change	 in	P450terp.	Finally,	a	new	P450,	CYP102L1,	was	classified	and	characterized	from	Mycobacterium	phage	Adler	and	its		potential	role	in	viruses	is	discussed.								
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Chapter 1 
Introduction to Cytochrome P450 
Introduction 
The cytochrome P450 superfamily (P450s or CYPs) is a broad class of heme-containing 
enzymes united by their rare heme thiolate ligation (Figure 1-1A) and conserved fold (Figure 1-
2). P450s are ubiquitous throughout the biosphere and are involved in a number of essential 
biological transformations that are of interest to scientists across a wide range of disciplines, the 
most well-known of which is their role in drug metabolism.1  First isolated and identified in the 
early 1950’s, the importance of these enzymes in mammalian systems was immediately clear in 
Figure 1-1. (A) Iron protoporphyrin IX or heme B represented as a circle bound to a cysteine-based thiolate 
in cytochrome P450. (B) UV-vis spectra of low-spin ferric resting state (black) and signature reduced CO-
bound state (red). 
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the role of detoxification of drugs and other hydrophobic molecules by the incorporation of one 
atom of atmospheric dioxygen.2-3 These initial findings began a crusade to understand the 
mechanism of these metalloenzymes and despite nearly 65 years of investigation, aspects of this 
protein’s mechanism still remain unclear.  
The initial discovery of cytochromes P450 as metabolic enzymes by Axelrod and Brodie in 
1955 demonstrated that an enzyme system in liver microsomes was capable of oxidizing foreign 
drugs and chemical compounds (xenobiotics) using NADPH as a reductant.2 The identification and 
isolation followed soon after from the independent studies by Klingenberg, Omura and Sato, and 
Estabrook.3-6 The name “P450” is derived from the electronic absorption spectrum that appears 
upon reduction of the enzyme’s active site heme cofactor followed by the incubation and binding 
of carbon monoxide (CO) (Figure 1-1B).3 This absorption spectrum was unique with respect to 
Figure 1-2. Overview of P450 structure with from proximal face (A) and side-on (B). (PDB ID: 2CPP) 
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other cytochromes as it displayed an intense absorbance maximum that underwent a 
bathochromic shift (red shift) from 420 nm to 450 nm, which did not occur in other heme proteins 
studied at the time, thus providing the basis for the name “pigment 450” or cytochrome P450.6  
Briefly, the electronic absorption spectra of porphyrin containing systems (e.g. heme), 
possess common spectral features consisting of 2 major bands: the Soret or B band (~400 nm) 
and Q band (a weak transition ~550 nm), which is often split into a and b bands.7 These bands 
arise from the strong π-π* transition that can be split and change in energy depending on a 
number of factors including the metal ion bound to the porphyrin, spin and/or oxidation state of 
the metal ion, and nature of additional coordinating ligands in the metal’s axial positions and are 
thus a sensitive probe of the state of the enzyme (vide infra). 
Nomenclature 
With over 55,000 P450 genes named to date from all kingdoms of life, development of a 
nomenclature system was necessary to keep track and identify their origin and function as 
annotated by sequence similarity.8 First, CYP for CYtochrome P450 precedes all named genes 
followed by an alphanumeric code that serves to describe the origin of the gene. The code is 
CYPxyz, where ‘x’ is a numeric code that indicates the enzyme’s family, ‘y’ is a letter denoting the 
subfamily, ending with a number, ‘z’, that indicates the member number.9 Maintained by David 
R. Nelson, a database of these P450s is available at: 
drnelson.uthsc.edu/CytochromeP450.html 
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According to the current naming convention: CYP1-50, CYP301-499 and CYP3001-4999 
are of animal origin, CYP51-70, CYP501-699 and CYP5001-6999 are reserved for lower 
eukaryotes, while CYP71-100, CYP701-999 and CYP7001-9999 are given to plants and CYP101-
299 and CYP1001-2999 to prokaryotes. CYP101A1, for example, describes a bacterial P450 from 
Pseudomonas putida that has a narrow substrate scope and serves as a model system for P450 
structure-function relationship and will serve as the major focus of this thesis.9-10 101 indicates 
that this is the first bacterial P450 with a particular known function or substrate to be identified, 
while A1 designates this as the first isoform identified with 101’s functionality. Within the P450 
Figure 1-3. Surface and ChemDraw representations of the conformational and coordination changes 
that occur upon substrate binding, which shifts the P450 from open (left) to closed (right). (PDB ID: 
4JX1, 2CPP) 
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community, this enzyme is commonly referred to as P450cam, where ‘cam’ is an abbreviation of 
the enzyme’s natural substrate, camphor, a small terpenoid that can serve as the P. putida’s sole 
carbon source.11 For comparison, one of the most intensively studied mammalian examples is 
CYP3A4, a membrane bound P450 expressed in the liver, which is responsible for the metabolism 
of a majority of xenobiotics ingested by humans.12  
Cytochrome P450 Structure 
With a significant number of P450 structures deposited in the protein databank (PDB) 
extending over a large range of organisms and functions, it is safe to conclude the P450 fold 
remains highly conserved despite large sequence diversity and substrate scope. One notable 
exception is the presence of an N-terminal tail that anchors insoluble (mitochondrial and hepatic) 
P450s to the membrane, although its removal does not seem to affect the overall structure.1 
Viewed from a plane parallel to the heme and normal to the axial H2O-Fe-S-Cys bonds (deemed 
the distal side of the heme), P450s exhibit a largely alpha-helical, triangular fold (Figure 1-2A). 
This conserved structure lends itself to a useful alphabetical naming convention that is used to 
describe various regions of the protein as seen in Figure 1-2.13 Of particular note and importance 
to this discussion are the B’, F, G, I, and L helices.  The B’ helix and associated B-C loop is one of 
the most flexible and important parts of any P450 fold.14-15 Its motion and structure are intricately 
tied to the F and G helices movement, which govern substrate access. The collective size and 
movement of these regions is the major factor in determination of substrate accommodation as 
well as regio- and stereo- selectivity of these enzymes and are often referred to collectively as 
the substrate recognition site (SRS).16-19 In particular, the F/G helices act as a lid to the active site 
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and determine what were traditionally referred to as the “open” or “closed” states of the enzyme 
(Figure 1-3). Contacts between the F/G helices and I helix are important in the regulation of the 
mechanism of P450.20-22 When the F/G helices move from the open to closed conformation, they 
introduce a kink in the I helix near the active site heme positioning a conserved threonine residue 
for a hydrogen bond network that is essential for O2 activation.22-24 
Figure 1-4. (A) Cytochrome P450 net reaction. (B) Catalytic cycle. (C) Mechanism of 
hydroxylation. 
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On the proximal side of the heme, near the beginning of the L-helix is the axially ligating 
cysteine that is largely responsible for P450s unique reactivity. Around this residue is a conserved 
loop geometry that tunes the sulfur’s electron donating character.25-27  
Cytochrome P450 Mechanism 
The mechanism of cytochrome P450 is complex, but logical and highly regulated. In this 
section, we will take a detailed look at the generalized active site mechanism of P450s to lay a 
foundation for the following discussion of how protein dynamics regulate this process. One of 
the unifying properties of the P450 family is the thiolate ligation that attaches a molecule of heme 
B, iron-protoporphyrin IX, to the protein scaffold, the porphyrin ring will be represented by the 
circle that encapsulates the iron, as in Figure 1-1A.  
We begin with the resting state of the enzyme, where an aquo- ligand occupies the sixth 
site in the axial position of the iron. The resting state has been probed by nearly every 
spectroscopic methodology and exhibits a ferric, six-coordinate, low-spin signal (S=1/2), that has 
been corroborated by X-ray crystallography.28-29 This substrate-free form has been shown to be 
in the “open” conformation to allow for access of substrate to the active site.29 Under these 
conditions, the redox potential is too low (-300 mV vs NHE) to abstract an electron from its native 
electron transfer (ET) partner protein.30-32 However, the role of substrate binding (RH) is twofold; 
it closes the protein active site from solvent by a conformational change of the F/G helices and 
hydrophobic substrate displaces the axial water providing a pentacoordinate system with a 
vacant site for O2 to bind (Figure 1-3). This change from six to five coordinate changes the ligand 
field such that the iron undergoes a spin-state change from low (S=1/2) to high-spin (S=5/2), 
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effectively increasing the redox potential of the complex.33 A ~130 mV (vs NHE) increase in redox 
potential to -170 mV (vs NHE) is sufficient to allow for reduction by its redox partner, which, for 
the purpose of this work, will predominately be putidaredoxin (Pdx) that has a redox potential of 
-230 mV (vs NHE).31, 34-35 This is the rate limiting step in the catalytic cycle.36  
The oxidation state change from ferric to ferrous allows for the binding of dioxygen. 
Formally, there are two ways to describe the oxygen bound intermediate, often designated as 
the “oxy-complex”. One is ferrous-dioxygen; the other, ferric-superoxide.37 In P450s, this 
intermediate has been demonstrated to exist predominately as the ferric superoxide species by 
Mössbauer spectroscopy.38 Additionally, the oxy complex is the origin of the auto-oxidation 
shunt, where the O2 unit is released as superoxide and the enzyme returns to its ferric resting 
state without completing the catalytic cycle.39-40 The stability of this intermediate varies from 
P450 to P450 and gives rise to an unproductive turnover otherwise known as “uncoupling” of 
electron transfer (ET) and substrate hydroxylation. Measuring the degree of uncoupling is 
Figure 1-5. Probable active site hydrogen bonding network of the oxy complex. 
Gly248 
Thr252 
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typically done by comparing the ratio of NAD(P)H consumed to product formed, which in a 
perfectly coupled system is 1:1.41 
 The ordering of the next steps in the catalytic cycle is still debated, but is generally 
accepted to be a proton coupled electron transfer (PCET) where the ET step occurs first forming 
ferric peroxide and is then coupled to a proton transfer where a solvent derived proton is 
abstracted to form the hydroxyperoxide complex, Compound 0.28 A second proton transfer 
occurs and the dihydroxoperoxy complex O–O bond undergoes a heterolytic cleavage and loss of 
a molecule of water, most likely driven by hydrogen bonding the distal oxygen.42-44  
 As a result of this heterolytic cleavage, the oxygen oxidizes the Fe(III) center and forms a 
formal Fe(V). However, this complex is highly oxidizing and thus removes an electron from the π 
system of the redox active porphyrin and forms iron(IV)-oxo (Fe(IV)=O) coupled to a delocalized 
ligand radical, known as Compound I (Cpd-I).26-27, 45-50  This initiates a hydrogen atom abstraction 
(HAT) from substrate and forms Compound II (Cpd-II), an iron-(IV)-hydroxo and a carbon-based 
substrate radical.51 A radical rebound mechanism, originally proposed by Groves, is allows for 
recombination of the substrate radical with the oxygen of Cpd-II.44, 52 Following product 
formation, the iron returns to low-spin Fe(III) state as product egresses from the active site and 
water rebinds the vacant coordination site. 
Cytochrome P450: Nature’s Aircraft Carrier 
Cytochrome P450 has been referred to as “Nature’s blowtorch” because of its ability to oxidize 
strong C–H bonds in a regio- and stereo- selective manner.48, 53 However, I would like to take this 
opportunity to extend the P450 metaphor to that of “Nature’s aircraft carrier”.  
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The launch mechanism of a fighter jet from an aircraft carrier is comprised of the tow bar 
attached to the plane’s nose gear through a slot in the deck and the hold back bar attached to 
the rear wheels to keep the jet in place. The catapult officer, or "shooter", prepares the catapults 
that will generate the necessary lift for takeoff. When the plane is prepared, the officer opens 
valves that fill the cylinders with high-pressure steam from the ship's reactors, which will be the 
driving force that propels the pistons at high speed and throw the fighter jet into the air. The 
engines are fully engaged, the holdback bars release the back wheels, and shuttle throws the 
plane to the end of the runway and the tow bar is released from the shuttle. Too much pressure, 
and the nose gear will be ripped off, too little and the plane will be thrown into the ocean. This 
system takes a 45,000-pound plane from 0 to 165 miles per hour in two seconds! Needless to 
say, any mistake in this process could be disastrous.54 
 Let us begin with the fighter jet, the competent oxidant, the reactive intermediate that is 
responsible for the chemistry, the infamous Compound I. This powerful intermediate draws its 
power from the primary coordination sphere; in particular, a thiolate ligation and redox active 
Figure 1-6. (Left) "Low Resolution" snapshot of fighter jet taking off from an aircraft carrier. (Right) "High 
Resolution" on the flight deck. 
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heme. It has a very specific mission that it must carry out effectively and with precision. In 
particular, its mission of C–H bond activation is thermodynamically demanding (E˚¢CH/C• = 1.5 V vs 
NHE), but Compound I carries out this oxidation without destroying its protein environment.26, 48 
Given the wrong conditions and the wrong instructions, the fighter jet, Compound I, could do 
some serious damage to the external scaffold, its own ship, the protein matrix. The fighter jet is 
hard to capture once it is on its mission, and in order to study it, it must be trapped within its 
native environment before leaving the runway.  
This brings us to the ship and some interesting facts about aircraft carriers. First, why an 
aircraft carrier? Given broad environmental conditions (i.e solvent, temperature, time), it is 
possible to get a fighter jet into the air from an airport runway, just as synthetic chemists can 
make general catalysts for C–H bond activation. The real question is, given the thermodynamics 
of C–H bond activation, how do you launch a 45,000 lbs fighter jet in 300 feet surrounded by a 
sea of water (aqueous environment) when traditional airport runways are 6000 to 8000 feet with 
2300 feet needed for takeoff alone? 
 From a bird’s eye view, or low resolution, one would be hard-pressed to define the exact 
mechanism of fighter jet launch. While one may be able to define some larger features of the 
carrier, such as the jet blast deflectors, runway lines, or the watchtower, it would be nearly 
impossible to provide an accurate picture of their dynamics. It is not until we go to high spatial 
and temporal resolution of someone standing on the flight deck that we clearly see the intricate 
regulatory processes required for take-off. Here, we can see the jet’s engines are fully engaged 
before take-off and excess energy is dissipated by the jet blast deflectors (Tyr/Trp channels)55-56, 
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the hold back bar is keeping the plane in place (Cys-loop)27, 57-58, the hydraulic catapult is fully 
pressurized (thiolate)59, and finally, the long-range communication that occurs between the 
tower and those on deck signals the jet for take-off (long range mechanical coupling)60 (Figure 1-
6). 
With high spatial and temporal resolution, we would see all of the pieces necessary to 
accomplish this complex task and why tight regulation is required if a process is efficient. But 
without this level of resolution, it would be impossible to understand how the structure of the 
carrier assists the fighter jet through a series of catapults that are initiated through long range 
networks from the tower to the deck.  
 As biochemists, we examine the active sites of the protein and test residues local to the 
activity and observe effects on rates or examine the overall fold. Again, at a modest resolution, 
we could probably identify the jet blast deflectors behind the planes and infer that they may have 
a role in redirecting or dissipating some of the jet’s energy before takeoff, providing a clue that 
jet engines may be fully engaged while the plane is in place. By removing them, what happens to 
the structure and function? From the overall structure, we could determine the tarmac and 
directionality providing a sense for which way takeoff should occur. Finally, we would observe 
the tower, perhaps indicating some form of long-range communication.  
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Figure 1-7. Classes of Cytochromes P450. FdR – Ferredoxin Reductase. Fdx – Ferredoxin. CPR – Cytochrome  
P450 Reductase. Fldx – Flavodoxin. OFOR – Oxoacid:Ferredoxin Oxidoreductase. PFOR – Phthalate Family 
Oxygenase Reductase. PGH2 –  Prostaglandin H2. TxA2 – Thromboxane A 
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 As inorganic chemists, we probe the jet. How much power does the jet possess? What are 
the minimum qualities a jet must possess to be able to do what the fighter jet does? We build 
our own jets to see how an increase in the size of the wings or flap material affects the jet’s 
precision. We gather significant insight this way, by stripping away the aircraft carrier and looking 
at the fine details from the bottom up.  
 As physical chemists, we use a combination of spectroscopic and computational tools to 
probe changes as a function of some perturbation and try to simulate their behavior and thus 
make a model carrier and jet mathematically and use it to predict the fighter’s behavior. 
 The point of describing these different approaches is to emphasize the necessity to 
continually integrate them to create a more complete picture of bioinorganic chemistry. We must 
integrate these processes to show how structure and function are related through dynamics that 
occur over a broad range of timescales and in complex environments. While they are necessarily 
disentangled by our distinct approaches, the natural systems are necessarily entangled for the 
purpose of efficiency. Nature does not have the leeway to be wasteful.  
Classes of Cytochromes P450 
 CYPs possess an immense diversity of function such as metabolism of xenobiotics, 
biosynthesis of natural products, and fatty acid decarboxylation and while the naming convention 
helps to distinguish P450s from one another, it is also helpful to be able to generalize about 
classes of P450 systems.61 In order to more easily discuss cytochrome P450 diversity, the enzymes 
are segregated by the most differential part of their mechanism, their electron donors or “redox 
partners”.62   Nearly all P450s require two sequential electron transfers from an electron donor. 
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The nature of this electron donor partner separates P450s into distinct classes. To date, there are 
greater than 10 classes of P450 (Figure 1-7). However, the two major classes, Class 1 and Class 2, 
tend to dominate the discussion and account for 90% of known CYPs.62 The majority of the focus 
of this work is on Class I systems.  
 Class I systems are comprised of three proteins: an FAD-containing reductase, a Fe2S2-
containing redoxin, and the P450.62 Overall, the FAD containing reductase binds NADH which 
undergoes a hydride transfer to the FAD cofactor. Two electron equivalents are subsequently 
passed one at a time from the reductase to the redoxin, which are then passed to the P450 in 
two sequential steps. This class of P450 is typically found in bacteria or attached to the 
mitochondrial membrane.  
 Class II P450s are two component enzymes usually associated with liver microsomes.62 In 
Class II systems, a flavin mononucleotide (FMN)-containing reductase removes a hydride from 
NADPH and passes the electrons from FAD to FMN to P450.  
 While the number of P450s in a eukaryotic organism far outnumber those present in a 
prokaryote, the sheer number of prokaryotic genomes provide unpresented diversity in terms of 
CYP function. All of this reactivity is tied to the ability for P450 to activate strong C–H bonds (~101 
kcal/mol) through the activation of atmospheric dioxygen. However, the diversity of reactivity 
that is possible by these enzymes is much broader. While most notable P450’s hydroxylate or 
epoxidate their substrates, they are also capable of N-, O- and S-dealkylations, sulphoxidations, 
deaminations, desulfurations, dehalogenations, peroxidations, and N-oxide reductions.63-64 
 
16 
 
 
 
 
 
 
Cytochrome P450cam (CYP101A1) 
 The first official report of P450cam was in 1968 when Katagiri et al. reported an NADH- 
dependent P450 in Pseudomonas putida.11 As a Class I system, hydroxylation of the physiological 
substrate D-camphor to 5-exo-hydroxycamphor requires three soluble components: a flavin 
adenine dinucleotide (FAD) dependent reductuase, putidaredoxin reductase (PdR), a Fe2S2-
containing depended redoxin, putidaredoxin (Pdx), and the cytochrome P450 (P450cam) (Figure 
1-8). These are expressed under the control of a polycistronic operon which is regulated by CamR, 
a camphor-dependent repressor. The solubility of this system made it much simpler to dissect 
the structure-function relationship and mechanism of hydroxylation. P450cam was the first 
cytochrome P450 to be successfully crystallized and its crystal structure was determined in 1985 
by Poulos et al.65 P450cam is an average size P450 comprised of 414 amino acid residues and a 
molecular weight of 46.6 kDa. In total, P450cam is composed of thirteen alpha-helices (A-L and 
Figure 1-8. (Top) P450cam redox components. (Bottom) Hydroxylation of d-camphor to 5-exo-
hydroxycamphor. 
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B’) and 5 beta sheets (ß1-5) (Figure 1-2A). Since this time, P450cam has served as the paradigm 
for structure-function relationships and mechanistic conclusions as the conserved features of the 
superfamily make it possible to generalize across both prokaryotic and eukaryotic P450s.66 Thus, 
here, we can expand on some of the specifics of the O2 and C–H activation mechanisms through 
the lens of P450cam (vide supra).  
 Cys357 coordinates the heme b iron in the axial position. Substrate access occurs on the 
distal side of the enzyme while Pdx binds to the proximal side. As the first structure of P450cam 
was solved in the presence of substrate, the enzyme was found in the closed form with no 
obvious access channel for substrate to enter. This led to a significant effort to identify the access 
channel. While advanced molecular dynamics techniques provided arguments for probable 
access channels,16-17, 19 it was not until decades later, in 2002, that Dunn et al.67 utilized 
ruthenium linked substrate mimics to crystallize the open conformation. Nearly a decade later 
still, Lee et al. solved the crystal structure of the substrate free form which revealed the same 
channel that was found in the 2002 study.29  
 With structures of the “open” and “closed” closed structures solved, it was possible to 
see how the B’, F, G, and I helices work together to change conformations for accommodating 
substrate. This was believed to complete the crystallographic characterization of the catalytic 
cycle as a series of intermediates such as the oxy complex had been previously characterized.53 
Prior to the solution of these structures, P450cam had demonstrated a strong sensitivity to 
concentrations of potassium by spectroscopy that was believed to affect substrate binding.68-71 
Through these crystal structures, a K+ binding site was revealed and further NMR studies by the 
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Pochapsky group corroborated the specificity and relative location of this site located on the B-C 
loop.72 Pochapsky also examined the active site mobility as a function of the potassium 
concentration and found that the B’ helix was significantly more mobile than previously thought. 
The potassium ion is coordinated by the backbone carbonyls of Glu84, Gly93, Glu94, and Y96 and 
stabilizes the secondary structure of the B’ helix, and thus stabilizes the closed conformation of 
the protein. Spectroscopically, addition of K+ in the presence of substrate increases the high spin 
fraction.68 Chapters 2 and 3 will discuss the critical role of the B’ helix in the mechanism of 
P450cam in detail. Pochapsky demonstrated not only the importance of potassium but also the 
role of proline isomerization, a concept that had not been previously observed in P450s.73 
Combining these results led to the hypothesis that the opening of these helices and 
movement of I helix is essential in freeing an aspartate residue (D251), adjacent to the active site 
threonine residue (Thr252), from a strong ion pair with an arginine located on the F helix near 
the F/G loop and that this aspartate residue (D251) plays an important role in the proton delivery 
mechanism of P450cam during the second ET step.21, 24 Specifically, in the crystal structures of 
the resting state, the hydroxyl group of the Thr252 sidechain forms a hydrogen bond with Gly248 
carbonyl that breaks upon O2 (or CN) binding.53, 74-75 The breaking of this bond and the widening 
of the I helix groove allows water to move into the active site and the backbone of Asp251 moves 
into a normal hydrogen bonding configuration. With this Thr252-G248 H-bond broken, there are 
now two H-bond acceptors poised within 3 Å of the distal oxygen atom which are suggested to 
assist in the protonation of the hydoxyperoxo complex and heterolytic cleavage mechanism to 
form Compound I (Figure 1-5). As previously mentioned, Asp251 is locked up in ion pairs with 
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K178 and R186 in the resting state, but, upon reorientation of the I helix and shifting to the open 
state, was hypothesized to assist in the shuttling protons to form and cleave the dihydroxyperoxo 
complex. Support for this hypothesis came from mutagenesis studies22, 44, 74 and was further 
corroborated by the X-ray crystal structure of the P450cam-Pdx complex where Asp251 is rotated 
toward the active site and in the open conformation.24  
 
Figure 1-9. Active site of closed substrate bound resting state structure of P450cam. (PDB: 2CPP) 
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Putidaredoxin and the P450cam-Pdx Complex 
 Within the catalytic cycle of cytochrome P450, there are two unique electron transfer 
events. The first of which promotes the binding of dioxygen and the second drives the 
protonation and subsequent loss of water to form the active oxidizing species, Compound I.  
In P450cam, both of these electron transfers are from putidaredoxin, Pdx. Pdx is a 2-iron-
2-sulfur containing ferredoxin that is comprised of 106 amino acids (11.6 kDa) capable of carrying 
out one electron redox processes with a redox potential ~-230 mV vs NHE.34 The amino acid 
composition of these ferredoxins is highly acidic with pIs ~3-4.  Early on, it was shown that the 
two ET events between Pdx and P450cam were distinct.76-78 In particular, it was shown that the 
first ET could be carried out by any reductant of the appropriate potential including non-
endogenous ferredoxins or cytochromes, while the second ET is specific and can only be carried 
out by Pdx. This stands in direct contrast to many other P450s where redox partner selectivity is 
more promiscuous and redox partners can serve a multitude of P450s or metalloenzymes. As the 
investigation of this specificity progressed, it was demonstrated that there was a conformational 
and allosteric role to this P450cam-Pdx interaction, deemed the “effector” role of Pdx and has 
been the subject of intense investigation.35, 79-81 Within this context, early mutagenesis studies 
identified Trp106, the terminal residue of Pdx, as a major contributor to this selectivity (Figure 1-
10B).82 
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Figure 1-10. (A) Substrate bound closed structure of P450cam. (B) Open structure of 
P450cam-Pdx complex (PDB: 2CPP, 4JWU) B-C loop and B’ helix (red). F/G helices (cyan). I 
helix (green). Pdx (orange) Trp106 (magneta). 
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However, determination of the structure of Pdx alone was a challenge. By NMR, the 
structure determination was hampered by paramagnetic broadening stemming from the two 
high-spin iron sites, a feat eventually overcome by the substitution of iron with gallium, however 
this change still induced deviations from wild-type (WT).83-87 By X-ray crystallography, it was not 
until 2003, where the substitution of two surface exposed cysteines (C73 and C85) for serines 
allowed for its crystallization and eventual solution.88 
 With the structures of both components in hand, a number of computational and 
mutagenesis studies sought to unravel the nature of this intriguing specificity. It was not until a 
decade later, that in our lab, Tripathi et al. was able to solve the crystal structure of the two 
proteins, P450cam and Pdx, complexed together in both the oxidized and reduced form.24 Shortly 
after, publication of the corroborative structures of the non-covalently linked structures by NMR 
and X-ray crystallography were published by the Ubbink group.89 
 These structures clarify the wealth of spectral and mutagenesis data and illustrate how 
critical residues and domains such as Trp106 of Pdx and the C helix of P450cam couple their 
motion to ensure a tight interface. Both crystal structures of the complex (oxidized and reduced) 
revealed the open conformation of the enzyme, supporting spectroscopic studies in which Pdx 
binding shifts P450cam to the low-spin form.35, 90-91 However, the structure of the dithionite 
reduced complex revealed product in the active site indicating ET, O2 activation, and substrate 
hydroxylation occurred within the crystal during data collection.24 In support of this active 
complex, is the breaking of the Asp251 ion pairs, which would free the side chain to participate 
in the proton relay network. 
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 Later, double electron-electron resonance (DEER) studies by Goodin indicated the 
conformational states accessible to P450cam are dependent on the oxidation state of Pdx and 
supported the binding oxidized Pdx to the open state.92 
Putidaredoxin Reductase 
The final component of the P450cam system is Putidaredoxin reductase or PdR, a 45.6 
kDa FAD-containing reductase. PdR removes a hydride from NADH and passes the two reducing 
equivalents to FAD then to Pdx. The PdR structure has been solved in addition to the PdR-Pdx 
complex.93-94 
 From a comparison of the P450cam-Pdx and PdR-Pdx complexes, an intriguing question 
arises about the nature of activity. While interfaces that Pdx makes with its partner proteins are 
relatively similar in both complexes, the PdR complex remains active in solution, while the 
P450cam complex is inactive. How and why are there differential activity between these 
complexes?  
Summary of Dissertation 
The remaining chapters will focus primarily on Class 1 cytochromes P450, in particular 
P450cam, and the interactions that occur between their substrates and their redox partners. In 
particular, Chapters 2 and 3 will focus on the model P450, P450cam. Chapters 2 and 3 open 
completely new territory in regard to the P450 mechanism. Chapter 2 will first examine the, to 
date, unknown cooperativity that occurs between an allosteric second substrate binding site and 
the formation of an egress channel. Chapter 3 will reveal how diatomic and redox partner binding 
can induce conformational changes that are predicted by molecular dynamics and controlled by 
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conformational changes never before crystallographically observed in a P450. Chapters 4 lays the 
ground work for understanding these redox partner interactions through other bacterial Class 1 
P450s. Chapter 5 examines the proposed roles of viral P450 through structure and bioinformatics. 
Chapter 6 unites and concludes the discussions within this work.  
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Chapter 2 
Substrate Dependent Allosteric Regulation in Cytochrome P450cam (CYP101A1) 
Introduction 
Cytochrome P450cam (CYP101A1) was first indirectly mentioned by Gunsalas in a 
communication regarding the microbial degradation of d-camphor in 1959.1  In this 
communication, a sewage bacterium, Pseudomonas putida, was demonstrated to utilize D-
camphor as its sole carbon source via enzymatic hydroxylation of camphor to 5-exo-
hydroxycamphor. Over the next decade, it would become increasingly clear that this “methylene 
hydroxylase” was of the same nature as the cytochrome (pigment-450) found in liver extracts 
that, just 5 years prior, were shown to be responsible for drug metabolism and steroidogenesis. 
From here, the realization of a highly expressible soluble P450 system that could be “easily” 
purified in high quantities led to a revolution in our understanding of this important enzyme and 
by extension, human metabolism. Over the next several decades, many groups worked to 
elucidate the mechanism of cytochrome P450cam. In particular, Gunsalas’ lab was at the 
forefront of its spectroscopic characterization and efforts were underway to explore all of the 
capturable states along the reaction pathway in addition to much theoretical work devoted to 
understanding P450s ability to activate O2 and C–H bonds.2-15 These early spectroscopic studies 
revealed the nature of critical states of the catalytic cycle that guides our thinking of P450s today.  
During the early investigation of P450cam, several interesting standards of practice were 
developed for working with the enzyme system. One of critical importance was the use of excess 
camphor. Camphor is a small bicyclic monoterpene that has limited solubility in water.  Since the 
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P450cam system is expressed under the control of a camphor-inducible polycistronic operon, the 
original expression and purification of P450cam components were performed from the native 
organism in the presence of saturating (excess) camphor.1, 16-18 To this day, however, it is not 
agreed upon what the saturating level of camphor is in solution. Even the seemingly most 
accurate figures disagree with one another; one comes from the Handbook of Aqueous Solubility 
Data, which cites 1600 mg/L at 25 ˚ C (10.5 mM)19, another from the International Labor 
Organization’s International Chemical Safety Cards (ILO-ICSC) published values of 0.12 g in 100 
mL at 25 ˚  C (7.9 mM)20 and the Merck index as 1 g in 800 mL at 25 ˚  C (8.2 mM)21. This discrepancy 
has propagated throughout the literature with reported experimental values ranging from 5 mM 
to 13 mM17-18, 22 and while this noticeably problematic concentration value is an issue on its own, 
an increasing level of complexity arises when considering that most of the experiments are 
performed in buffer and salt at various temperatures potentially broadening an already 
ambiguous solubility limit.  
Figure 2-11. Closed camphor bound (left), open with ruthenium linked substrate mimic (magenta) 
(center), open substrate free (right) structures of P450cam. (PDB: 2CPP, 5IKO, 3L62) 
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 However, this role of substrate concentration, while sitting in the back of my mind, was 
not the direct reason for the following investigation. It was actually a back of the envelope 
calculation that really bothered me and gave rise to the following study. Given the in vitro rates 
of NADH consumption and the fact that if P. putida survives on camphor, then the use of NADH 
to produce ATP changes 2-fold, since the ratio 1:1 camphor to acetyl-CoA  vs 2:1 glucose to acetyl-
CoA (full calculation in Appendix A), it was not possible to reconcile that a cell of P. putida could 
survive on these rates, pointing to flaws in our understanding of the enzymatic system. It also 
points to an existent hypothesis that P450cam’s highly regulated mechanism prevents wasting of 
valuable reducing equivalents (i.e. uncoupling).23 If efficiency and effective use of energy is the 
name of the game, then problems arise when considering the dogma surrounding P450cam’s 
structure-function relationship.  
Prior to the determination of the structure in 1985, several solution studies examined 
substrate binding in P450cam by electronic absorption, magnetic circular dichroism, and EPR 
spectroscopies.3, 8, 11-12, 14-15, 24-28 Some of these initial investigations examined the effect of 
concentration on the spin-state of the enzyme, trying to correlate heme spin state signatures to 
the binding of camphor. As early as 1975, it was observed that at low-concentrations of camphor, 
P450cam to substrate stoichiometry remains 1:1, and the high-spin fraction of the enzyme 
increases with increasing concentration of camphor.29-30 Yet, at sufficiently high concentrations 
of camphor, the P450 shifts back to a low-spin state. As pointed out by Lipscomb, the low-spin 
state (S=1/2) observed in the presence of high-concentrations of camphor (g=1.97) does not yield 
the same g-values as in its absence (g=1.91), indicating that this low-spin species is distinct from 
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the resting state. This new feature was not fully characterized, but was attributed to the 
possibility of a second molecule of camphor binding to P450cam. These results were later 
corroborated by EPR binding studies by Lange24, 28-29, as well as Hui bon Hoa31-33, who 
demonstrated by high-pressure UV-vis spectroscopy that at high concentrations of camphor 
there was a shift back to a low-spin species, suggesting a second-binding site.  
However, in 1985, the structure of P450cam bound to its substrate revealed a 1:1 
stoichiometry between protein and substrate.34 This crystal structure is debatably, other than 
the discovery of the enzyme itself, the most important contribution to the P450 field to date as 
this provided the P450 community with deep insight into the spectroscopic and turnover 
experiments, revealing atomic details of stereo and regioselective hydroxylation, simultaneously 
putting an end to the suggestion of a second binding site. However, while camphor was bound 
to the active site, this structure presented no obvious channel for active site access (Figure 2-1). 
For several years that followed this structure determination, computational chemists 
would be confined to a single set of atomic coordinates to calculate potential pathways of entry 
and exit. This was somewhat expanded with the determination of P450BM335, P450terp36-37, and 
P450eryF38 in the mid to late 90’s and led to some ingenious strategies of finding low energy 
pathways for entry and escape including Random Expulsion Molecular Dynamics (REMD), steered 
molecular dynamics and metadynamics.39-42 All these approaches correctly predicted the result 
of the 2002 crystallographic study where ruthenium tethered substrates revealed the classic 
entry channel, channel 1.43 In 2010, a structure of P450cam in the camphor-less “open” state as 
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well as several other P450 structures supported a common mechanism of substrate binding as 
they possess a highly conserved fold.44 
This idea, while elegant, presents an apparent conundrum. Why and how would nature 
evolve an enzyme that can act as the first step in a mechanism of metabolism to possess a single 
channel where active site seeking substrate competes against an escaping molecule of 
hydroxylated product? This idea seemingly violates one of nature’s design principles of efficiency 
and clearly required further investigation.  
 As an aside, in computational chemistry, we are finally reaching the point where atomistic 
simulations of incredible complexity can be carried out to time scales that are on par with many 
Figure 2-12. Location of the proposed allosteric (labeled allo) camphor binding site. Camphor (yellow) 
is tucked into a hydrophobic pocket between the C and E helices. 
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of the biological phenomena that we, as biochemists, are interested in. I believe that that this 
has fundamentally reshaped our thinking of the cellular milieu and biology, as these models are 
able to bring many critical structures and experimental snapshots “to life”. Substrate binding in 
P450cam, in particular, is reported to occur on the microsecond timescale is now achievable by 
standard molecular dynamics techniques.  
 In the following chapter, microsecond timescale unbiassed molecular dynamics 
simulations are utilized to integrate and begin to answer two outstanding questions in the field 
of P450cam. 1) Is there second binding site, and if so, where and what is its relevance to catalysis? 
2) How does substrate bind to and egress from the active site of P450cam?  
Results and Discussion 
Identification of an Allosteric Camphor Site 
The initial goal of this study was to see if camphor placed in the solvent cushion surrounding the 
protein would diffuse through channel 1, between the F/G loop and B’-helix, and bind near the 
heme. To simulate camphor in solution binding to substrate-free P450cam, substrate was placed 
in the outer solvent cushion. At first, this was done with just one molecule of camphor.  Previous 
studies by our lab utilized principle component analysis (PCA) as a tool to understand the open 
and closed state conformational dynamics.45 PCA allows us to reduce a highly dimensional 
dynamic space with many degrees of freedom down to a finite number of correlated vectors. For 
molecular dynamics simulations of P450cam, the first two vectors, PC1 and PC2, represent the 
two dominate correlated motions of the protein and mapped on this new space. The vector that 
we chose to project on is the average Ca coordinates between the open and closed crystal 
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structures. This approach is useful for looking at the population of conformational states of 
P450cam in open and closed during an MD simulation. As can be seen in Figure 2-4, simulations 
of the open conformation are highly diffuse while the closed conformation is much less diffuse 
indicating that upon the binding of substrate, the protein tightens down on the camphor 
molecule. Previously, our lab looked at the effect of the presence of redox partner on the 
conformational state of P450cam and found that MD simulations of the complex equilibrate 
between open and closed, or in a “semi-open” state.45  
Using PCA as a guide, simulations containing one molecule of camphor exhibited a 
predominately open conformation, starting and ending in the open form. Upon visual inspection, 
substrate never enters the active site. Increasing to three molecules of substrate, however, a 
Figure 2-13. Principle component analysis (PCA) of molecular dynamics simulations of the open (red), 
closed (blue), and Pdx-bound (green) structures for 500 ns each. Crystal structures are plotted as 
boxes. PCA adapted from Batabyal et al. 
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striking change to the population occurs, where we start in the open, end in the closed, and 
appear similar to previous simulations of the P450cam-Pdx complex.  
In this case, three camphor molecules were placed in the solvent cushion giving an 
effective three-fold excess, an experimentally relevant condition and within the limit of solubility 
of camphor in water given the size of the solvent box.  In all of these simulations, a molecule of 
camphor binds to a pocket on the “back side” of the F/G helices in between the C/D/E/F helices 
(Fig 2-5). This site is defined by V118, V123, K126, L127, L166, and T217 (Figure 2-5) and is the 
same region that NMR studies found to be perturbed in the presence of high camphor 
concentrations.46-47 
These NMR results can be interpreted as either camphor binding to the active site 
resulting in long-range perturbations at the L166 site or direct binding of camphor to the L166 
region. Our MD simulations indicate that perturbation of L166 could be due to direct interactions 
between camphor and L166.  
Figure 2-14. PCA of simulations with 1 (left) and 3 (right) molecules of camphor. Starting coordinates in 
cyan and final coordinates in red overlaid on open and closed simulations (black). 
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Binding to this allosteric site is accompanied by widening of channel 1 as well as formation 
of a new active site access channel 2 (Fig 2-1). This second channel was formerly identified as a 
possible egress channel using modified molecular dynamics techniques such as random expulsion 
MD (REMD) and metadynamics.42, 48 Cojocaru et al.42 also suggested the formation of this new 
channel, but neither the REMD nor metadynamics studies postulated allostery or explored the 
correlation of channel formation with a second camphor site. We found that a good measure of 
channel 2 formation is the distance between the Ca atoms of S83 and S102, which is ~5 Å in the 
closed structures and ~7-13Å when channel 2 is open. Experimentally, S83 was identified by 
Asciutto et al.49 as a hinge region that undergoes sizable chemical shifts in the absence of 
camphor. Using the S83-S102 distance as a criterion for channel 2 formation, we determined a 
strong correlation between occupancy of the allosteric site and formation of this new channel 
Figure 2-15 The structure of P450cam at 378 ns. Binding of camphor (yellow) to the allosteric site 
results in the opening of a new active site access channel. 
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(Fig. 2-6A).  When there is no substrate present in our simulations the S83-S102 distance 
fluctuates between 5-7 Å (Fig 2-6B). Upon addition of a single camphor in the crystallographic 
pose, channel 2 remains shut at 5 Å.  Binding of camphor to the allosteric site shifts the S83-S102 
distance to ~7 Å. In simulations where both binding and egress events occur the second channel 
opens to nearly 12 Å and the open state is strongly preferred.  
If binding to the allosteric site results in formation of a more open active site and binding 
to that site is much weaker than to the active site, then binding ought to favor low-spin P450cam 
at high concentrations of camphor. Indeed, multiple studies have found that at concentrations 
of camphor well beyond that required for saturating the active site, P450cam shifts back toward 
low-spin.29, 50-52 This shift was attributed to the binding of a second camphor molecule and is 
consistent with our results where camphor binding to the L166 allosteric site opens the active 
site thereby shifting P450cam toward low-spin. At the time of these equilibrium binding studies, 
the location and relevance of this site was not known. Our simulations also are consistent with 
the NMR work of Yao et al.53 In this study, a second camphor site with a KD≈43 µM was located 
15-16 Å from the heme iron by paramagnetic T1 relaxation. Uniform labeling with 13C Thr showed 
that a Thr residue is perturbed at high camphor concentrations but peak overlap prevented 
determination of its exact location.53 The allosteric site in our simulations fit these data well as it 
is ~15 Å from the heme iron and T217 is in the allosteric pocket.  Finally, Colthart et al. found that 
the L166A mutant in the presence of excess camphor favors high-spin P450cam even though 
enzyme activity was decreased.46 Camphor binding to the L166 allosteric site should be 
weakened in the L166A mutant and, as a result, excess camphor will no longer favor low-spin 
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P450cam. Our MD simulations and allosteric site hypothesis are consistent with NMR46, 53 and 
equilibrium binding data29, 33, 50.   
Figure 2-16. (A) Camphor population in the allosteric binding pocket as percentage of 
simulation time. Run 01 and Run 02 were performed with 4 fs time steps and HMR for 1.4 
µs each. Run 03-07 were 1 µs each and utilized 2 fs timesteps and no HMR. (B) B loop 
residues S83 to S102 Ca distance as a percentage of total aggregate time in simulations 
containing no camphor (black dashed), 1 camphor in its crystallographic pose (black solid), 
1 molecule using HMR (solid dark grey), 3 camphor molecules with 2 fs steps (solid light 
grey), 4fs steps and HMR (solid red), and with 3 camphor molecules and potassium counter 
ions. 
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Crystallographic Support for the Allosteric Binding Site 
Direct observation of camphor binding to our proposed allosteric site would require 
trapping P450cam in a thermodynamic local minimum of the substrate free open form and then 
introducing substrate. This is precisely what Lee et al.54 accomplished in solving the crystal 
structure of substrate-free P450cam in the open state (3L62). In this structure, the B’ helix 
(residues 90-101) is not visible in the electron density due to disorder, which opens channel 2 in 
a similar way to what we observe in the MD simulations. In a separate study, Liou et al.55 soaked 
these same substrate-free P450cam crystals in excess camphor and found that camphor binds in 
the active site but in multiple conformations (5IK1). If our allosteric model is correct, then we 
would expect to observe camphor binding to our proposed allosteric site in the 5IK1 structure.  
Figure 2-17. Fo-Fc electron density maps contoured at 4.0 s (blue) and 7.0 s (green). In the substrate-free 3L62 
structure the lobes of electron density are consistent with water molecules as originally modeled. However, 
in the 5IK1 structure the much larger electron density is not consistent with ordered water but with a much 
larger molecule(s).   
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We therefore reexamined the electron density maps for both structures (Fig. 2-7). In the 
camphor-soaked structure, there is a peak of electron density at 7s near our proposed allosteric 
site which is not seen in the camphor-free structure.  Since the only difference in the two 
experiments is soaking with camphor in 5IK1, the larger lobe of electron density near L166 is 
consistent with an orientationally disordered camphor as predicted by our MD simulations.  
  Additional crystallographic support for this binding site comes from a P450cam homolog, 
CYP101D1. CYP101D1, from Novosphingobium aromaticivorans, is not the sole P450 for its host 
organism and possesses 44% sequence identity and a 1.2 Å Ca RMSD to P450cam, however, its 
camphor-binding and catalytic properties are remarkably close to those of P450cam.56-57 Of 
particular interest for this study, is the conservation of the allosteric site, which retains four of 
Figure 2-18. CYP101D1 soaked with camphor in the presence of 1,4-dioxane. A polder map (green) 
contoured at 5 s and 2Fo-Fc electron density map contoured at 2 s (blue) with analogous Leucine-
168 (cyan). 
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the six residues identified in our initial MD simulations: K128, L129, L168, T225. The crystallization 
and structure determination of CYP101D1 was performed both in the absence and presence of 
camphor.57 However, within their crystallization solution is 12% 1,4-dioxane, which, in the 
absence of camphor, binds to the active site. Upon soaking camphor into their crystals, substrate 
binds to the active site, but additionally, a large peak of density appears around L168, the 
analogous allosteric region. After further investigation and re-refinement of the deposited 
structure factors, it is clear that this density should be attributed to a molecule of 1,4-dioxane in 
both subunits. However, the obvious question becomes, why, when camphor is not present, is 
dioxane in the active site, but not the allosteric site? And, why, upon camphor soaking does 
camphor bind to the active site and dioxane bind to the allosteric site given the structures are 
prepared in the same conditions with the exception of soaking?  
An Allosteric Model 
The rather dramatic effects of camphor binding to the allosteric site on access channel 
formation offers a dynamic picture relevant to catalysis and cooperativity. This also provides 
evidence for the growing realization of how weak transient allosteric interactions can serve to 
prime and direct enzymatic catalysis.58-59 A series of snapshots derived from one of the HMR 
simulations is shown in Fig 2-9. After ~60 ns, one camphor molecule binds to the allosteric site, 
pulling back on the F/G lid thus widening channel 1 allowing a molecule of camphor to enter the 
active site. Substrate binding to the allosteric site also pulls on the B’ to C-helix loop through 
mechanical coupling creating a second channel to the active site (Fig. 2-9, channel 2). This is seen 
in every simulation we performed. This long-range coupling from the allosteric site to the 
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substrate access channel (about 10 Å) allows for a second molecule of camphor to enter the 
active site. Once the camphor enters the active site via channel 1 in the 250 ns time range, the 
F/G helices tighten down on the substrate, which weakens binding to the allosteric site so 
camphor dissociates from the allosteric site. At 312 ns, the substrate molecule is ejected through 
channel 2 and Y96 flips out toward solvent. The ability for Y96 to adopt both the “in” and “out” 
Figure 2-19. The two relevant channels are indicated by 1 and 2.  60 ns- A camphor molecule (yellow) 
binds to the allosteric site (allo) priming channel 2 to open. 240 ns- Binding of a second molecule to the 
active site widens channel 2. Between 240 and 310 ns, one molecule dissociates from the allosteric site. 
310 to 312 ns- The active site molecule is swept from the active site via Tyr96 (cyan) through the B’ region. 
334 ns- A new molecule binds to the allosteric site. 378 ns- Y96 flips back to the active site upon binding 
two molecules substrate, restarting the cycle. 
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orientations is consistent with crystal structures of P450cam in the open state. This also offers an 
explanation for the potassium specific effects seen in P450cam and why increasing [K+] slows 
turnover rates.60 Potassium is known to increase the high-spin fraction of P450cam.28-29, 61-62 The 
K+ binding site is in the B’ loop near Y96 thus stabilizing the B’ region in the closed conformation.62 
As a result, binding to the allosteric site is weakened and without the ability to form channel 2 to 
allow rapid substrate/product binding/egress, activity decreases. We tested this hypothesis by 
replacing the sodium counter ions that neutralize the charge of our simulations with potassium. 
As seen in Fig 2-6, the replacement of sodium with potassium shifts the channel to a more closed 
Figure 2-20  Mechanical coupling of the residues I150 and L252 to occupancies of the active and 
allosteric site. Changes in distances of the sidechains (center of mass) (black) is affected by 
changes in occupancy of the active site (red) and allosteric site (cyan). There is an average distance 
of 7.67 Å (purple). Active site occupancy was calculated as ≥10 Å from sidechain O of Thr252. 
Allosteric site occupancy was calculated as >=8.5 Å from L166 Cg. 
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state. However, while the results support experimental conclusions, we have not been able to 
determine whether the mechanisms of closed state stabilization are the same in our simulations.  
Binding to the allosteric site favors the more open form which enables a second camphor 
molecule to enter the active site and the formation of channel 2 that provides a pathway for 
rapid substrate binding and product egress.  Y96 operates as a swinging arm to “grab” entering 
substrates when Y96 is in the “up” orientation and then the “in” orientation helps to hold 
camphor in position for stereo- and regio-selective hydroxylation. Product then can depart via 
channels 1 or 2, but our data suggests that the channel is unidirectional: entry via channel 1, 
egress via channel 2. Since active site binding favors the closed form there is a dynamic interplay 
between the closed/open transition and active site/allosteric site binding.  
We observe additional changes that are consistent with NMR studies as detailed by 
Colthart et al.46 Using a combination of mutagenesis and chemical shifts, it was demonstrated 
that I160 in the E helix and L250 in the I helix are mechanically coupled. These two residues 
directly contact one another in the closed state with a distance between Ca atoms ~5.3 Å. In our 
HMR simulations where egress is observed, the side chains of Ile160 and L250 have a correlation 
coefficient of 0.910 over 1.4 µs (1), where C is the average correlation, V is a motion vector per 
frame and N is the total number of frames.  𝐶(𝑎, 𝑏) = ∑)*∙),	.  
 Eq. 2-1. Correlation Coefficient  
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With an average distance of 7.67 ± 1.05 Å, the fluctuations in distance between the two side 
chains are driven by events of binding and dissociation at the allosteric and active site (Figure 2-
10).  However, camphor binding to the allosteric site and opening of channel 2 forces these two 
residues to break all non-bonded interactions with the distance between Ca atoms now 8.2 Å. In 
our simulations, just as Colthart et al.46 described, it is this coupling that allows the I helix to 
undergo a deformation upon substrate binding and straightening upon camphor 
ejection/removal from the active site.  
Allostery and Redox Partner Binding 
The cooperative interaction between the allosteric site and active site also has relevance 
to the binding of Pdx. Since both Pdx binding and allosteric site binding promote the open form, 
then Pdx and allosteric site binding work synergistically and promote each other’s binding. In 
addition, both Pdx binding and allosteric site binding promote the same structural changes at the 
Pdx docking site.  L358 is positioned at the Pdx binding docking site and must adopt an alternate 
Figure 2-21. L358 adopts a different rotamer in the closed and open states. In the open conformer when 
Pdx is bound or when the allosteric site is occupied, L358 rotates up to contact the heme. 
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rotamer conformation when Pdx binds (Fig. 2-11). As shown in Fig. 2-11, the L358 N-Ca-Cb-Cg 
dihedral is ≈-70˚ in the closed (2CPP) and substrate-free open (3L62) structures.34, 54 However, in 
the P450cam-Pdx complexes (4JXI, 4JWU, 3W9C) the L358 dihedral ranges between 55-65˚.23, 63 
This change is necessary to enable Pdx to form a tighter interface with P450cam. Our simulations 
show that when the allosteric site is occupied with camphor the L358 rotamer becomes more 
flexible and when substrate is driven through channel 2 the rotamer is the same as in the 
P450cam-Pdx complex where P450cam is open. Therefore, the allosteric site is not only coupled 
to the active site, but also the Pdx docking site. When L358 is in the Pdx-bound conformation the 
Leu side chain is closer to the heme and thus “pushes” on the proximal face of the heme. There 
is good evidence that this “push” effect is coupled to changes on the opposite side of the heme 
that favors the open form of P450cam. When O2 binds to ferrous P450cam the I helix undergoes 
a significant widening that enables waters essential to catalysis to move into place as part of 
proton relay network required for O2 activation. The direction of I helix motion is from closed to 
partially open. CO, often used as an O2 mimic, causes none of these changes in wild type P450cam 
but the CO-L358P mutant more closely mimics those changes induced by O2 binding.64-65  This 
indicates that the L358P mutant can more easily adopt the open conformation.64-66 The structural 
basis for these effects is that the more rigid sterically restricted P358 side chain “pushes” on the 
proximal face of the heme and these changes are transmitted to distal side and I helix. Thus, the 
L358P mimics the close to open switch accompanying Pdx binding and camphor binding to the 
allosteric site. These results suggest how two unique interfaces can be presented for electron 
transfer upon binding of Pdx with and without substrate in the allosteric site. Binding at the 
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allosteric site which favors open P450cam also favors Pdx binding. As suggested by Tripathi et 
al.23 the closed state is inactive because the proton relay network involving the essential Asp251 
is locked down by tight salt bridges. However, in the open state these salt bridges are broken 
thus enabling Asp251 to serve its function in proton transfer to the iron linked dioxygen. 
We close our discussion with the potential biological implications of these results. While 
seemingly quite complex, the logic of these transitions in the requirements for balancing rapid 
turnover with association/dissociation processes and the utilization of camphor as a carbon 
source is rather simple. The expression of P450cam, PdR, and Pdx is under the control of the 
CamR repressor although the P450cam proteins are constitutively expressed at low levels in the 
absence of camphor.67 Therefore, at low camphor concentrations, the active site, but not the 
allosteric site, is occupied and the enzyme is in the closed inactive conformation. At higher 
camphor concentrations, where camphor now can be used as a carbon source, the allosteric site 
comes into play and together with Pdx binding switches P450cam to the more open active 
conformation.  This view is consistent with what is known about how the CamR repressor that 
controls the expression of P450cam, Pdx, and Pdr is controlled. CamR is released from the CamR 
regulatory DNA sequence only at high camphor concentrations.68 Like many dimeric bacterial 
repressors, CamR binds two ligand (in this case, camphor) molecules. The first exhibits a KD≈ 0.06 
µM, but CamR remains bound to the CamR regulatory DNA sequence. Binding of the second 
camphor molecule with a KD≈14 µM results in the release of CamR and expression of the P450cam 
gene products.  This means P450cam and its redox supporting proteins are highly expressed only 
at high levels of camphor, >10 µM, which is well above the KD for camphor binding to the 
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P450cam active site.  Therefore, the entire CamR system including the low amounts of 
constitutively expressed P450cam are shutdown at low levels of camphor where camphor cannot 
serve as a useful carbon source thus avoiding the unnecessary consumption of NADH. 
Conclusions 
The results of our MD simulations provide a detailed structural model on the allosteric 
interplay between substrate binding, redox partner interactions, and O2 activation that are 
consistent with a wealth of experimental data. Most importantly, the novel allosteric binding site 
identified in this study is consistent with NMR and crystallographic data46, 55, 69 as well as 
equilibrium binding data of Lange et al.29 Changes in specific residues observed in our simulations 
are consistent with mutagenesis data as well as differences observed in the crystal structures of 
the open and closed states. From these simulations, it is clear how allosteric regulation in 
P450cam may affect the formation of a second channel for product egress, the role of Tyr96 and 
potassium specific effects seen in solution, as well as the distortion of the I helix and long-range 
mechanical couplings. Such strong correlation with experiments provides a high level of 
confidence that the allosteric site identified in our simulations and the changes associated with 
substrate entry and egress provides a realistic structural model of allostery in P450cam. One 
possible advantage for such a level of allosteric control is to ensure that neither substrate 
binding/product egress are limiting under steady-state conditions. Therefore, at high levels of 
camphor, the kinetic processes of substrate binding and allostery are masked and, as observed 
experimentally, the first electron transfer step becomes limiting.70  
 
52 
 
 
 
 
 
 
Experimental Section 
Computational Methods 
Molecular dynamics (MD) simulations were performed as previously described.45, 71 In 
brief, one structure was used for the simulations, the P450cam open structure in 4JX1 where Pdx 
was removed. The P450cam in this structure is basically the same as the open P450cam crystal 
structure solved without Pdx (3L62).54 The rms deviation of Ca atoms between the two structures 
is 0.37 Å. We chose 4JX1 because in this structure the entire protein is clearly defined in electron 
density maps while in 3L62 residues 91-94 are not visible. Therefore, using 4JX1 required no 
modeling to obtain a complete structure for MD simulations. The protein was solvated in a 
rectangular box of TIP3 waters with a 10 Å cushion and Na+ ions were added in order to maintain 
net neutrality. Asp297, which is buried in the active site and forms a H-bond with a heme 
propionate, was protonated. Camphor was placed manually on the distal side of the protein for 
simulations including external camphor. One molecule was introduced near the known entry 
channel and the second and third at a distance ~10 Å from the protein, near the cutoff distance 
for long-range interactions in our simulations. Structures were minimized for 1000 cycles, 
allowing only H atoms and solvent molecules to move followed by an additional 1000 cycles 
where all atoms were allowed to move. Production runs were then carried out using Amber 14 
or Amber 16.72 In order to sample functionally important time scales, we first utilized a technique 
known as hydrogen mass repartitioning (HMR).73  In brief, the size of simulation time steps is 
dictated by the fastest vibrations that occur in the system, which are H atom vibrations. By 
repartitioning masses of heavy atoms to their adjacent hydrogen atoms, one can effectively slow 
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down the vibrations of these bonds while preserving the overall mass of the system thereby not 
increasing viscosity. This allows larger time steps to be taken in order to capture large 
conformational motions that take place over longer intervals effectively cutting the 
computational time in half. We later found that motions relevant to allosteric interactions and 
camphor binding did not require the time scales necessitating HMR.  For HMR runs, topology files 
were modified by the parmed.py python script and both protein and water masses were 
repartitioned using the command HMassrepartition dowater.73 HMR runs were performed using 
4 fs timesteps and non-HMR runs were performed using traditional 2 fs steps suggested by the 
SHAKE algorithm. All simulations were performed using a random initial velocity with each run 
having a different initial velocity (ig=-1). Two runs were carried out using HMR and 4 fs timesteps 
for ~1.4 µs each with 3 molecules of camphor.  Three runs with HMR and 4 fs timesteps were 
performed with 1 molecule of camphor for 1.6 µs, 350 nanoseconds and 310 nanoseconds. Five 
additional runs using 2 fs timesteps and no repartitioning were performed for 1 µs. Five runs 
were performed for 500 ns with no camphor in the simulation. Five runs were carried out with 
potassium for a total runtime of 3.5 µs. Data analysis was carried out in cpptraj and VMD.74-75 
Trajectory images were produced in Pymol (Schrodinger). 
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Chapter 3 
Ligand and Redox Partner Binding Generates a New Conformational State in Cytochrome 
P450cam (CYP101A1) 
Introduction 
As discussed in chapters 1 and 2, after binding substrate and displacement of the active site 
water, P450cam undergoes a low to high spin transition. High-spin P450cam’s redox potential is 
sufficiently high enough to abstract an electron from its native redox partner, putidaredoxin 
(Pdx). This is followed by the binding of O2 to the open axial coordination site on P450cam’s heme 
active site.1 The first ET is the rate limiting step of the P450 catalytic cycle.2 Therefore, to prepare 
any of the critical intermediates, an electron must first be transferred to P450cam. This first 
electron transfer only requires a reductant of the appropriate potential such as dithionite or 
cytochrome b5 and thus many of the P450cam intermediates have been studied in the absence 
of Pdx. Although, in its native context, putidaredoxin is present during both electron transfers 
and its influence on P450cam’s conformation those intermediate complexes are unknown. 
In particular, a hallmark of the P450cam system is that the second electron transfer step can 
be supported by only Pdx so it has long been thought that Pdx plays an effector/allosteric role.3 
This effector role has been demonstrated by numerous spectroscopic methods,4-10 but the 
underlying conformational dynamics that give rise to its specificity have only recently begun to 
emerge. Crystal structures of P450-redox partner complexes are challenging and rare with only 
three structures to date.11-13 The most recent are the covalent and non-covalent structures of 
P450cam-Pdx determined by both X-ray crystallography and NMR.13-14 These structures provided 
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the first direct structural evidence of how allosteric effects of Pdx may be achieved. The binding 
of Pdx to substrate bound P450 pushes P450cam towards the open conformation consistent with 
earlier spectroscopic evidence that demonstrated Pdx binding shifted substrate-bound P450cam 
back towards the low-spin state.10 This shift to an open conformation was hypothesized to allow 
for the formation of a water mediated proton relay network to enter the active-site channel and 
Figure 3-1. (A) P450cam (white) with the B-C loop (red) forming channel 2 in complex with Pdx 
(orange). (B) Rotated by 90˚ counter clockwise to show the allosteric site (green). (C) A cross section 
of the complex. 
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free active site residue Asp251 from a strong ion pair with F helix residue Arg186, which 
participates in a proton delivery relay to the distal heme-bound oxygen for O-O bond scission.13, 
15 
Related to both substrate and Pdx binding is perhaps the most important step of the P450 
catalytic cycle, the binding and activation of molecular dioxygen. The synergistic timing of O2 
binding, activation, and turnover is critical to ensure efficient coupling and prevent unproductive 
turnover and release of O2 as reactive oxygen species (ROS) such as superoxide or peroxide. While 
these interactions have been extensively investigated within the context of P450cam-camphor 
interactions,3, 16 Pdx’s involvement with substrate and O2 dynamics are not well understood. 
While the structure of substrate-bound P450cam and dioxygen has been solved 
crystallographically, determination of the analogous structure of the oxy-complex bound to Pdx 
is not as straight forward. It has been previously demonstrated that in the presence of substrate 
and Pdx, X-ray radiation alone can reduce either P450cam and/or Pdx to initiate substrate 
turnover and form product within the crystal.13 Beyond the challenges related to the instability 
of the oxy complex, formation of the oxygenated intermediate within the crystallized complex 
would surely bring a similar result upon X-ray exposure.  
In order to study the effects of oxygenated intermediates of P450, both cyanide and carbon 
monoxide have been utilized as stable mimics of O2.17-18 However, binding of CO to P450 does 
not confer many of the conformational changes that are known to occur upon dioxygen binding.5, 
18 This may be due to electronic changes that occur upon CO binding and a lack of charge on the 
distal oxygen. Oxy complexes of heme proteins are best described as ferric-superoxide rather 
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than ferrous-oxy so the distal O2 oxygen atom carries a negative charge.19-20 The ferric-superoxide 
complex is electronically similar to the ferric-cyanide complex as CN- has a negative charge on 
Figure 3-2. Several changes occur in the B-C loop of P450cam. Two prolines in the structure undergo 
cis-trans isomerization including (A) Pro89 that also moves to a distance of 3.6 Å from Tyr29 as well as 
(B) Pro105. (C) Tyr96 also rotates out of the active site where it H-bonds with the camphor carbonyl 
oxygen. Camphor (yellow) Heme (red). 2Fo-Fc maps at 1 s (blue). 
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the distal nitrogen. Indeed, the P450cam-CN- complex results in the same changes in local protein 
and solvent structure as the O2-bound intermediate, while CO and NO complexes do not.17, 21-23  
 In this chapter, the structure of substrate bound P450cam-Pdx complexed with cyanide as 
an axial ligand at a resolution of 2.15 Å is presented. Quite unexpectedly, we found that cyanide 
induces large structural changes that results in the formation of a new opening to the active site 
we have termed channel 2. Our recent molecular dynamics (MD) simulations showed that 
binding of the substrate, camphor, to a site on the protein well removed from the active site 
results in the formation of this same channel 2.24 Thus, the present work provides experimental 
verification of structural change predicted by MD simulations as well as defining a novel 
conformational state of P450cam that may have relevance to enzyme function.  
Results and Discussion 
In Chapter 2, MD simulations demonstrated how allosteric control of P450cam by a 
second molecule of camphor may provide a mechanism of activation by opening a primary and 
secondary channel. To date, the formation of the second channel has never been verified 
experimentally. Owing to the limits of classical MD, the role of O2 binding, product formation, 
and Pdx interaction were not demonstrated in our proposed model, but these processes are 
intricately governed by protein-substrate interactions. 
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Figure 3-3. Alignment of P450cam crystal structures and molecular dynamics snapshots. Top: Crystal 
structure of the closed complex (cyan), Pdx bound complex (magenta) and Pdx-CN complex (green) 
showing the degree of movement of both the F/G helices (left) and I helix right. Bottom: Molecular 
dynamics snapshots revealing the degree of similarity between the Pdx-CN structure (green) and 
simulation before (yellow) and after (blue) egress of camphor from the active site through channel 2. 
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P450cam and Pdx were covalently crosslinked using a bismaleimide crosslinker between 
two non-native cysteines far from the protein-protein interface. The protein complex was 
crystallized and soaked with excess cyanide. To confirm the binding of CN-, a UV-vis spectrum of 
the crystal was taken using the microfocus beamline and the Soret peak is significantly red shifted 
indicating the presence of bound CN- (Fig 3-6). The most significant stuctural changes between 
the complexes with and without CN- bound are the widening of the F/G loop and opening of the 
B’ channel (channel 2, Fig 3-1). This indicates that the binding of CN- to the heme induces large, 
ordered conformational rearrangements within the crystal.  
 In Chapter 2, it was suggested how substrate binding to a second site may prime the 
opening of a second channel and how Pdx may preferentially bind to this open structure to 
contribute to product egress via mechanical coupling. Overlaying the CN- bound complex 
structure with our prior simulation egress event reveals significant similarities (Fig 3-3). Unlike 
the other P450cam-Pdx complexes, the F/G helices have moved to a completely open 
conformation. This allows for breakage of the Arg186-Asp-251 ion pair, which, in our structure, 
is present in two rotameric conformations revealing how binding of dioxygen and Pdx may break 
this pair allowing for Asp251 to participate in proton delivery as suggested by Tripathi et al.13 
Polder maps demonstrate the bifurcation of the Asp251 residue (Fig 3-3). The rotamer where 
Asp251 is oriented in toward the active site is in an ideal position to mediate proton transfer to 
dioxygen.  
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However, the substrate access channel (channel 1) is not completely exposed in either of 
the molecules as the B’ helix has lost nearly all secondary structure but remains hydrogen bonded 
to the F/G loop. The movement of the F/G loop and the unfolding of the B’ helix leads to channel 
2 formation while channel 1 remains closed. This new channel provides an egress path for 
product and is associated with dynamic movement of Tyr96. This is important since in the closed 
state Tyr96 provides an H-bond to the camphor carbonyl oxygen. However, when CN- binds to 
the P450cam-Pdx complex Tyr96 flips out of the active site (Fig 3-2C). To demonstrate the 
dynamics of this channel, we previously utilized the Ser83 to Ser102 Ca distance as a measure of 
channel 2 formation, which in all crystal structures where the B loop is ordered, is ~5 Å.24 In the 
Figure 3-4. Polder Map of Asp-251 in two rotameric 
conformations. 2Fo-Fc at 1 s (blue) and Polder map 
at 4 s (green). 
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CN- complex structure, however, the S83 to S102 distance is ~9.5 Å, which is in good agreement 
with our simulations that in order for substrate egress to occur channel 2 opens to beyond 7 Å.  
NMR studies hypothesized that conformational switching in P450cam is dictated by an X-
proline (X-Pro) cis-trans isomerization, but this has never been observed in a crystal structure. 
Specifically, OuYang et al. identified Pro89 as the most likely candidate for controlling this 
process.25 They observed two distinct camphor orientations when substrate bound P450cam was 
reduced and bound to carbon monoxide (CYP-S-CO) and was then titrated with reduced Pdx 
(Pdxr). The time scales of the observed chemical shifts were in good agreement with reported 
time scales of catalyzed proline cis-trans isomerization. Catalyzed X-Pro cis-trans isomerizations 
are accelerated ~106 times faster than uncatalyzed transitions (~0.01 s-1).25  The binding of CN- to 
P450cam-Pdx results in the cis to trans isomerization of the Ile88-Pro89 bond which breaks a 
bifurcated hydrogen bond from the carbonyl of Pro89 to the NH groups of Ala92 and Gly93 that 
allows the B’helix to lose secondary structure but remain hydrogen bonded to the F/G loop. NMR-
directed molecular dynamics suggested that the barrier of this isomerization is lowered by a 
distortion of the ideally planar Ile88-Pro89 O-C-N-C∂ (ω) dihedral from 180˚ to ~166˚ in the trans 
form. The conclusions of those simulations are supported by the Ile88-Pro89 ω dihedral angles 
in our structure, which are distorted to 167˚ and 169˚.  Tyr29 was also hypothesized to be 
important in the controlling the isomerization process, and, when compared to the closed 
structure, has moved from a distance of ~2.7 Å to 3.6 Å, nearly out of hydrogen bonding range 
(Fig 4A). Pro106 also undergoes cis to trans isomerization assisting in the opening of channel 2 
and forces greater alignment of the backbone carbonyls effectively increasing the stability of the 
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C-helix (Fig 4B). The Pro-Pro motif at the end of the B-C loop is conserved in a number of bacterial 
P450s and suggests that this mechanism may not be unique to P450cam.26  
 One surprising observation from the structure is the orientation of the 7-propionate 
group. In every crystallographic structure of P450cam deposited in the Protein Data Bank, the 
Figure 3-5. Two different views of the active site of P450cam with camphor (yellow) and CN (grey) 
bound to heme (red). Leu358 (green) has rotated to accommodate Pdx and pushes on the heme, 
where the 7-propionate has rotated and broken its interactions with Asp297. 2Fo-Fc contoured 
at 1 s (blue, right).  
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propionates take on identical conformations, with 7-propionate C1A-C2A-CAA-CBA dihedral 
between -100˚ and -110˚. In the cyanide structure presented here, the 7-propionate dihedral has 
rotated by ~180˚ to 89.9˚ and 85.3˚ respectively (Fig 3-5). Hayashi et al. reconstituted P450cam 
with a “one-legged” heme to demonstrate how the 7-propionate along with Asp297, Arg299, and 
Gln322 act to protect the active site from solvent entry.27 Asp297 is believed to be protonated 
(H++ server: http://biophysics.cs.vt.edu/) and involved in hydrogen bonding with heme 7-
propionate. In the CN- complex, Asp297 breaks this hydrogen bond with the propionate revealing 
how Asp297 may participate in hydrogen bonding to camphor after binding O2 allowing for 
retained regio-stereoselectivity. In our unrestrained MD simulations, this same H-bond breakage 
of 7-propionate is associated with substrate egress. (One NMR structure exhibits a similar 
geometry; however the heme structure was determined by molecular dynamics.) 
We previously postulated that the dihedral rotation of the Leu358 side chain had 
relevance in Pdx binding and product formation.24 Once again, Leu358 N-Ca-Cb-Cg rotates ~130˚ 
from the open-closed structure (2CPP) ~-70˚ to a dihedral angle of 59.3˚ and 56.9˚ in each 
monomer, respectively. This rotation allows for Pdx to create a tighter interface with P450cam 
and has been associated with the “push” effect coupled to changes on the distal side of the heme 
that favors the open form of P450cam.5-6, 28 Here, we can see how Leu358 rotates upon CN- and 
Pdx binding and induces changes on the distal side of the heme as well as the heme itself that 
favor an open state. 
 Why CN- binding induces such large changes illustrates the intricate coupling of distant 
regions of P450cam with one another which have been well documented by NMR studies.25, 28-33 
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To make room for CN- the I helix must move and since the F and G helices contact the I helix and 
the F/G loop region contacts the B’ helix, all these regions move in concert. These large changes 
are possible because Pdx is holding P450cam in the partially open state. In the closed state, O2 
and CN- binding, P450cam is locked down in the closed state and these large changes cannot take 
place. Even so, O2 and CN- binding to closed P450cam results in local change in the I helix which 
are in the direction toward the open state.17, 22 Pdx binding releases these restraints thereby 
enabling the protein to undergo these large conformational rearrangements. 
Conclusions 
The P450cam-Pdx-CN- structure illustrates the magnitude of conformational changes that 
P450s can undergo and defines a new conformational state of P450cam. We were quite surprised 
that these large changes including cis-trans proline isomerization can occur within the confines 
of a crystal lattice. Although CN- is a good mimic of O2, the current structure cannot represent an 
active complex owing to the location of the camphor in channel 1. In our original structure of the 
P450cam-Pdx complex the product, 5-exo-hydroxycamphor, is positioned in the substrate 
binding site but a second camphor molecule is bound just above the product in channel 1 (PDB 
4JX1). In the CN--complex, camphor is positioned about 2 Å up the channel away from the 
productive binding site and thus cannot represent the structure just prior to O–O bond cleavage 
and substrate hydroxylation. We postulate that opening of channel 2 has allowed productively 
bound substrate to escape while rearrangements of the F/G and B’ regions trap the second 
camphor molecule in channel 1. It is unlikely that O2 alone can result in the same changes we 
observe with CN- primarily because the oxy-P450cam complex is very unstable when bound to 
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oxidized Pdx while clearly the CN- complex is quite stable. This is probably because Pdx shifting 
P450cam to the open state in the absence of electron transfer promotes rapid autoxidation of 
the oxy-complex. It thus seems more likely that the stability of the CN- complex has enabled 
trapping of P450cam in this new open conformational state. What provides an additional level of 
confidence that the CN--induced structural changes are functionally relevant is the consistency 
with our previous MD simulations that show an allosterically regulated change in structure 
resulting in the formation of channel 2 very similar to what happens when CN- binds. This is 
reasonable since the regions in the immediate vicinity of CN- binding in the I helix and those of 
the proposed allosteric substrate binding site ~16 Å away are mechanically coupled. Perturbing 
one perturbs the other. Therefore, the CN- complex provides a snapshot along the reaction 
coordinate after substrate hydroxylation and product egress through channel 2 while the 
substrate molecule in channel 1 is poised for movement to the productive binding site once Pdx 
dissociates. 
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Table 3-1.  X-ray crystallography data collection and refinement statistics for 
P450cam-Pdx-CN complex. Values in parentheses are for the highest resolution shell. 
 
  P450cam-Pdx-CN 
Data collection  
Space group P 1 21 1 
Cell dimensions  
a, b, c 57.36 110.30 88.62 
a, b, g 90, 107.67, 90 
Resolution (Å) 
 
40.6  - 2.15 (2.227  - 2.15) 
     Rmerge 5.0 (34.76) 
Total reflections 108983 (10818) 
     Unique reflections 54970 (5453) 
     CC1/2 0.997 (0.632) 
I/s 10.42 (2.46) 
Completeness 96.26 (96.33) 
     Redundancy 2.0 (2.0) 
Refinement  
Rwork/Rfree 0.1979 (0.2714)/ 0.2558 
(0.3457) 
 
Number of atoms 8572 
Protein 8015 
Water 395 
Ligands 162 
RMSD Bond lengths (	Å) 0.005 
RMSD Bond angles 0.63 
     Average B factor 40.26 
     Ramachandran 
Favored/Outliers (%) 
97.03/ 0.00 
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Materials and Methods 
Crystallization 
P450cam-Pdx crystals were prepared by hanging drop method as previously described.13 To 
prepare the CN--bound complex, crystals were soaked in mother liquor containing 50mM KCN 
for 15 min. Mother liquor supplemented with 15% glycerol was used as a cryo-protectant and 
crystals were flash frozen in liquid nitrogen before data collection.  
Data collection and Refinement 
Data were collected from single crystals at the Stanford Synchrotron Radiation Lightsource 
(SSRL). Diffraction images were indexed, integrated, and scaled using Mosflm and Scala in the 
CCP4 package.34 P450cam-Pdx complex crystals structure (4JWS)13 without cofactor was used as 
a search model in molecular replacement using Phaser. The final structure contains two 
molecules of the P450cam-Pdx complex per asymmetric unit. The Phenix suite35 was used for 
structure refinement. All reflections were used for refinement except for 5% excluded for Rfree 
calculations.35 The structural model was revised in real space with the program COOT36-37 based 
on sigma-A weighted 2Fo-Fc and Fo-Fc electron density maps. The final refinement statistics are 
given in Table 3-1. The final structure was refined to 2.15 Å resolution with an Rfree of 25.6 % and 
Rwork of 19.8%.  
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Structural Analysis 
The final refined model consists of two molecules of complex (P450cam A-chain + Pdx C-chain, 
P450cam B-chain + Pdx D-chain) in the asymmetric unit. All four chains are highly ordered and 
more than 97.0% of the residues were located in the core region of Ramachandran plots as 
determined by MolProbity.38 We did not observe any significant change in Pdx although during 
data collection the Fe2S2 center in Pdx very likely gets reduced. When Pdx is reduced the 45-46 
peptide flips allowing the peptide NH group to donate a hydrogen bond to the Fe2S2 center in the 
reduced state. In our structure, this peptide is in the reduced conformation.   
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Chapter 4 
Redox Partner Interactions with P450terp (CYP108A1) 
Introduction 
The importance of cytochromes P450 in biological processes cannot be overstated. 
However, as discussed in chapter 1, a significant portion of these enzymes exist as membrane 
tethered, multi-component systems (Fig 1-7) presenting a significant challenge for both high-
yield expression and purification, as well as experimentation (e.g. crystallization).  Hence, the 
utility of the highly expressible and soluble P450cam system is immeasurable and while its global 
Figure 4-1. Comparison of P450cam (PDB: 2CPP) (A) and P450terp (PDB: 1CPT) (B). F/G helices (cyan) 
and B/C loop (red). (C) Hydroxylation of a-terpineol to 7-hydroxy-a-terpineol catalyzed by P450terp. 
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properties such as architecture and general mechanistic intermediates are conserved, it remains 
unclear to what extent the exact mechanistic transitions (i.e. effector role of the redox partner) 
of P450cam can be generalized to the superfamily.  
As discussed in the previous chapters, the working hypothesis is that the redox partners 
act in an effector role to push P450s to an open conformation allowing the iron-linked O2 access 
to solvent protons for proton coupled ET (PCET). However, only three structures of P450 redox 
complexes have been solved crystallographically, P450BM3-BM3FMN reductase1, P450scc-Adx2, 
and P450cam-Pdx3, so limited structural information is available to guide our understanding of 
these processes. The complex of P450BM3 to its FMN-containing reductase domain, while from 
a prokaryote like P450cam, was solved in the substrate-free form. Therefore, questions remain 
whether redox-partner induced structural rearrangements occur in the presence of substrate. 
The P450scc-Adx complex is mammalian and does not exhibit these same structural changes and 
leads us to our second hypothesis, that this effector role is perhaps specific to bacterial P450s. In 
bacterial systems, where a single, plasmid encoded P450 is responsible for the metabolism of 
some carbon source, it is necessary for tightly coupled regulation of substrate binding, redox 
partner binding, and conformational changes to ensure efficient metabolism and prevent wasting 
of potentially valuable reducing equivalents. Recent work by the Plettner group has provided 
critical insight into the toxicity of camphor to Pseudomonas putida4, as well as the ability for P. 
putida to undergo P450cam-dependent camphor-induced taxis5, thus supporting the notion that 
increased regulation is required for energetic efficiency and survival of the organism. In order to 
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investigate the extension of the mechanism discussed and developed in chapters 2 and 3, it is 
necessary to examine homologous systems to P450cam.  
 P450terp or CYP108A1 is a close homologue of P450cam that serves as the sole P450 for 
its host Pseudomonad, and, in addition, is a plasmid-borne inducible system that allows its host 
to utilize a small terpenoid, α-terpineol, as its sole carbon source.6 P450terp catalyzes the 
transformation of α-terpineol to 7-hydroxy-α-terpineol (Fig 4-1). Similar to P450cam, P450terp 
requires an electron transfer (ET) from a small Fe2S2 ferredoxin, terpredoxin (Tdx), which is first 
reduced by an FAD-containing reductase, terpredoxin reductase (TdR), which oxidizes NADH. 
While highly homologous in its biological role, atomically, P450terp possesses only 22% sequence 
identity to P450cam. Additionally, its redox partner, terpredoxin, shares a 36% identity with Pdx 
and does not possess an analogous C-terminal tryptophan (W106), which plays an important role 
in the P450cam-Pdx interactions.3, 7  
 Other than P450cam, P450terp is one of the first P450s to be crystallographically 
characterized.8-9 The Peterson lab, similar to the lab of Gunsalus, was intrigued by the use of 
microbial metabolism for the controlled functionalization of organic substrates and isolated 
P450terp by cultural enrichment of growth media containing α-terpineol from a swamp in North 
Dallas.6 The genetic structure and sequence were determined in 1992 and was followed shortly 
by a substrate free structure of P450terp in 1994 at 2.3 Å resolution.6, 8 A few additional works 
by Peterson, as well as the lab of Hui Bon Hoa, characterized some thermodynamic and kinetic 
properties of the enzyme10-11, but none were performed with respect to the interactions with its 
redox partner, terpredoxin (Tdx). Although, an NMR structure of Tdx was published by 
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Pochapsky, the active site was necessarily homology modeled due to paramagnetic broadening 
by the two high-spin Fe sites.12  
 This chapter focuses on the recombinant expression and purification of the P450terp 
system and investigates its selectivity with regard to its redox partner.  
Results and Discussion 
While the structure of P450terp was solved in the by Hasemann et al.8, it was solved in 
the absence of substrate. As a result, a large portion of the F/G loop is unresolved and the binding 
mode of the substrate remains unknown. To this end, crystallization of all components of the 
P450terp system was attempted. However, the only successful conditions were the repetition of 
the structure in the substrate free form which showed no deviation from the previous solution, 
and terpredoxin. 
Structure of Tdx 
  Like many ferredoxins, terpredoxin is a relatively small Fe2S2 protein with high acidic 
amino acid content (pI = 3.8). Its iron-sulfur cluster is ligated by four of five total cysteines present 
in the protein: C39, C45, C48, C86 and C43 is non-ligating. While initially expressed and purified 
as the wild-type (WT) protein, crystallization of WT (even in the presence of excess dithiothreitol) 
led to small needle-like crystals that could not be easily separated and thus did not lend 
themselves to diffraction. This is similar to the situation encountered with the crystallization of 
putidaredoxin (Pdx), the native redox partner of P450cam.13 In Pdx, there are six cysteine 
residues, and in order to achieve long-term stability and successful crystallization conditions, the 
two non-ligating cysteines were mutated to serines (C75S and C85S). It was believed that these 
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free cysteines may be reactive and contribute to the formation of intermolecular disulfide 
bridges. As Tdx also possesses one non-ligating cysteine (C43), mutation of this residue was 
hypothesized to improve the overall stability and aid in crystallization of the protein.  
Figure 4-2. (A) Asymmetric unit of the C43S Tdx forms a dimer similar to Pdx. (B) The 2Fo-Fc electron 
density map at the [2Fe–2S] cluster in the Tdx structure contoured at 1 s. (C) Alternative view of a 
cartoon representation of a monomer of Tdx. (D) An overlay of the ribbon structure C73S/C85S Pdx 
crystal structure (PDB: 1XLO) (cyan) and C43S Tdx (gray). 
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 The Tdx C43S mutant yielded small plate-like crystals that diffracted to 2.15 Å. Pdx and 
Tdx share 36% sequence identity. However, attempts to utilize either the NMR solution structure 
or Pdx as molecular replacement search models were unsuccessful. However, bioinformatic 
analyses revealed a ferredoxin from Rhodobacter capsultus possessing a 41% sequence identity 
with a crystal structure available. FdxE or Ferredoxin-6 (PDB: 1E9M) was used a successful 
molecular replacement search model.14   
Modeling of the Complex 
Utilizing the crystal structure of P450terp (PDB: 1CPT) and the crystal structure of Tdx-
C43S, we can construct a model of the potential complex based on the structure of P450cam-
Pdx.3 We find that, while the RMSD is 0.65 Å between Pdx and Tdx and critical electron transfer 
residues are conserved in each P450, these two ferredoxins have significantly different interfaces 
presented to their respective P450s (Fig 4-3). In particular, at the C-terminus of Pdx is a 
tryptophan residue (Trp-106) which is necessary for the effector role that regulates ET.3, 7 This 
residue is not present in Tdx. Not only is it not present, the C-terminus of Tdx ends in an alanine 
(A105 which was disordered within our structure) and does not extend to reach to potential 
interface between the two proteins. Additionally, arginine-66 of Pdx forms an ion pair with 
glutamate-76 of P450cam while Tdx-P450terp has a potential charge reversal of this ion pair with 
aspartate-66 of Tdx and lysine-65 of P450terp. While the analogous residue to Asp38 of Pdx is a 
glutamate (E38) in Tdx, this residue has been shown to be critical for activity and highly sensitive 
to mutation.16 
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Figure 4-3. (A) P450cam-Pdx complex with interface residues highlighted in green with heme in pink spheres 
(PDB: 4JWS). (B) Modelled complex of P450terp-Tdx based on P450cam complex with analogous residues 
highlighted in green sticks. (C) Superposition of Tdx on Pdx from complex (4JWS) (gray) and Tdx (cyan). Key 
residues in Pdx that interact with P450cam are shown in sticks and their analogous residues in Tdx. C-termini 
are shown with red arrows. 
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Additionally, it is known that crystals of oxidized ferredoxins, such as Pdx, undergo 
significant photoreduction upon exposure to synchrotron radiation.15 As such, Tdx is assumed to 
be in the reduced conformation as no precautions were taken to minimize this process. This is 
partially justified by the geometry of the C45-A46 peptide. Upon reduction, ferredoxins, including 
Pdx, a peptide bond flips to readjust the hydrogen bonding to the sulfurs of both the cluster and 
ligating cysteine residues. This was originally documented in Anabena PCC7119 where, upon 
reduction, the Cys46-Ser47 peptide bond flips to provide a hydrogen bond to sulfur S1 and 
stabilize the increased negative charge on the cofactor.15  The same conformational change of 
Cys45-Ala46 has been documented in Pdx.16 In the Tdx-C43S structure, the Cys45-Ala46 peptide 
is in the CO-out conformation and A46’s nitrogen is 3.3 Å from sulfur 1 of the cluster supporting 
a reduced state. 
Stability of the Oxygen Complex of P450terp 
One of the first ways the effector role of Pdx was demonstrated was by the destabilization 
of the oxygenated complex of P450cam in the presence of camphor.17 Presumably, oxidized Pdx 
should not react with the oxycomplex of P450cam. However, oxidized Pdx accelerates the decay 
of the oxycomplex P450 by 150-fold. We hypothesize that this rate acceleration is due to the 
conformational change induced by Pdx, which from both crystallographic and spectroscopic 
studies is a closed to open transition.3, 17-18 Thus, Pdx opens the active site and accelerates the 
oxidation of the oxycomplex back to the ferric high spin resting state.  A similar effect was 
observed in the P450cam homologue, CYP101D1, and its native redox partner Arx. In the case of 
101D1, the decay rate of the oxycomplex was accelerated ~33-fold in the presence of Arx.19 
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However, by UV-vis and resonance Raman spectroscopic experiments, the effector role of Arx 
pushes CYP101D1 towards a high-spin state; opposite of Pdx’s influence on P450cam which 
increases of the population of the low-spin species.19 
In an effort to understand if a similar effector role is exhibited by terpredoxin on P450terp 
in the absence of a complex crystal structure, the decay of the oxygenated complex of P450terp 
was monitored by stopped-flow UV-vis spectroscopy. Terpredoxin exhibits a similar effect as Pdx 
and Arx, but its effect is not as pronounced. Addition of a 2-fold excess of oxidized Tdx to 
P450terp decreases the stability of the oxy complex by ~16-fold with rate of 0.3200 ± 0.04 s-1 
compared to an autooxidation rate of 0.0212 ± 0.002 s-1 in the absence of Tdx (Fig 4-4). While the 
destabilization is not as prominent as P450cam or 101D1, it is significantly faster than the rate of 
Figure 4-4. (A) Oxy-P450terp (red) decays to high-spin ferric P450terp (black). (B) Decay of the 
oxycomplex in the absence (data-black solid, fit-red dashed) and presence of two-fold Tdx (data- solid 
gray, fit- dashed blue) at room temperature (23 ˚C). 
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auto-oxidation and suggests that Tdx may exhibit a similar conformational change in P450terp as 
is observed in P450cam. 
NADH Oxidation 
  Associated with the conformational change induced by Pdx, a hallmark feature of 
the P450cam system is the lack of cross-reactivity with any ferredoxin other than its native Pdx.20-
22 To examine whether this selectivity is generalizable to other P450s, P450terp was tested for 
cross-reactivity with a selection of redox partners from homologous systems. The standard 
method for examining selectivity is monitoring the substrate dependent consumption of 
NAD(P)H by its characteristic absorbance at 340 nm. In these experiments, NADH is incubated in 
the presence of all of the protein components required for turnover of substrate and a 
background rate of NADH oxidation is determined. After mixing and incubation, substrate is 
added to the reaction. If the redox partner can successfully provide electrons for turnover to the 
P450, there is a substantial increase in the rate of NAD(P)H oxidation. These rates are reported 
 
Reductase Redoxin P450 NADH (min-1) 
TdR Tdx P450terp 691.72 ± 24.716 
PdR Pdx P450terp N.R. 
FldR* Cdx P450terp N.R. 
ArR Arx P450terp 272.5 ± 12.75 
TdR Tdx P450cam N.R. 
TdR Tdx P450cin N.R. 
TdR Tdx P450lin N.R. 
PdR Pdx P450cam 973.08 ± 146.15 
 
Table 4-1. Substrate dependent NADH oxidation rates. *-NADPH. N.R- No Reactivity. 
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in Table 4-1. Of the systems tested, only the native system, Tdx, and Arx, from the 101D1 system, 
allowed for successful NADH consumption. However, the observation that P450terp exhibits 
cross-reactivity with Arx contradicts the current hypothesis of redox partner selectivity to 
preserve energetic equivalents. Moreover, Arx was also shown to exhibit cross reactivity with 
another Pseudomonad P450, P450lin that oxidizes a monoterpene, linalool, which it can utilize 
as its sole carbon source (data not shown). Additionally, Tdx was not able to provide electrons to 
the homologous P450s. 
Conclusion 
 Our initial hypothesis was that Pseudomonad P450s that are plasmid borne and function 
as the first step of oxidative assimilation of a non-glucose carbon source are necessarily tightly 
coupled and selective for their redox partners in order to prevent the wasting of valuable 
energetic equivalents (i.e. NAD(P)H). Additionally, we hypothesized that this selectivity is 
conformationally regulated. However, the extreme selectivity for redox partner may not extend 
beyond P450cam as Arx is able to pass electrons to P450terp and P450lin. While the degree of 
coupling of non-native redox partners remains to be determined, it appears that there still is a 
degree of selectivity and that some form conformational regulation may be involved. Preliminary 
resonance Raman data suggest that the behavior of P450terp may be similar to CYP101D1 upon 
redox partner binding, where the high spin fraction is increased upon introduction of redox 
partner exactly the opposite of P450cam. 
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Materials and Methods 
Terpredoxin Reductase (TdR) 
 A pET-28A expression vector containing TdR gene with a thrombin cleavable N-terminal 
His-tag was ordered from GenScript. The plasmid was transformed into E. coli C41 cells. A 100 
mL starter culture was inoculated and shaken at 180 rpm overnight at 37° C. The starter culture 
was used to inoculate 7 L of TB media and the cells were grown at 37° C at 225 rpm to an optical 
density (OD) of ≥1.0 before induction via 1mM IPTG. At this time, growth conditions were slowed 
to 80 rpm and cooled to 18° C. Cells were harvested after 48 hours. The cells were broken by 
microfluidization, high-speed centrifuged, and the supernatant was loaded onto a Nickel-NTA 
column. TdR was washed with buffer containing increasing concentrations of imidazole in a step-
wise fashion until elution with 150 mM imidazole. To remove the His-tag, a thrombin digest (50:1) 
was performed for 2 hours at room temperature. Completion of digestion was assessed by 
MALDI-TOF mass spectrometry. TdR was loaded back on to the Ni-NTA column and the flow 
through was collected. The protein was concentrated and purified further by size-exclusion 
chromatography. Purified protein was assessed by SDS-PAGE and UV-vis spectroscopy (Fig 4-5). 
In addition, the extinction coefficient was determined by denaturation assay23 to be 12.2 mM-
1cm-1 at 455nm. 
90 
 
 
 
 
 
 
 
Terpredoxin (Tdx) 
A pET-28A expression vector containing Tdx gene with a thrombin cleavable N-terminal 
His-tag was ordered from GenScript. This expression vector did not work and the Tdx gene was 
cloned (vide infra) into a pET-17b vector with no His-tag. The plasmid was transformed into E. 
coli C41 cells. A 100 mL starter culture was inoculated and shaken at 180 rpm overnight at 37° C. 
The starter culture was used to inoculate 14 L of 2xYT media and the cells were grown at 23° C 
(RT) at 80 rpm for 48 hours. The flasks were then removed and allowed to stand for 2 days. Cells 
were then harvested, washed with 20 mM potassium phosphate buffer (KPi) pH 7.4 containing 5 
mM DTT, and lysed by microfluidization. Cell lysate was centrifuged and the supernatant was 
loaded on to DE-52 anionic exchange column. The column was washed with an excess of buffer 
(20 mM KPi pH 7.4, 5 mM DTT) and the brown band (Tdx) was excised and loaded onto a clean 
Figure 4-5. (A) SDS-PAGE gel of Terpredoxin Reductase. (B) UV-vis spectrum of TdR. 
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DE-52 column. The protein was eluted with a gradient of 0-600 mM KCl. Fractions exhibiting 
A280/415>0.3 were combined and concentrated then loaded onto a Q-sepharose column. The 
column was washed with 20 mM Kpi pH 7.4, 50 mM KCl, 5 mM DTT and eluted over a gradient of 
0-600mM KCl. Fractions with A280/415>0.6 were combined, concentrated, and purified further by 
size-exclusion chromatography. Purified protein was assessed by SDS-PAGE and UV-vis 
spectroscopy (Fig 4-6). In addition, the extinction coefficient was determined by BCA assay to be 
6.5 mM-1cm-1 at 415 nm. 
 
Cloning of Tdx from pET-28A to pET-17b 
The pET-28a plasmid was digested with restriction enzymes NDE1 and XHO1 for 2 hours 
at 37 ˚C. The digestion products were run on a 0.8 % agarose gel, extracted and purified with a 
Figure 4-6. (A) SDS-PAGE gel of Terpredoxin. (B) UV-vis spectrum of oxidized (black) and 
reduced (red) Tdx. 
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Nucleospin gel extraction kit. Purification was assessed by an additional 0.8% agarose gel. 
Ligation into the pET-17b plasmid was performed overnight at 15 ˚C. The ligated mixture was 
transformed into competent Gold cells. Successful transformations were confirmed by blue-
white X-gal assay. 
Site-directed mutagenesis of Tdx-WT to C43S 
 Tdx plasmid (100 ng/µL) was incubated with PFU Turbo DNA polymerase and 20 µM of 
forward and reverse primers: F: 5’-GTGCGGCGGCTCAAGTGTCTGCGCTAC-3’, R: 5’-
GTAGCGCAGACACTTGAGCCGCCGCAC-3’.  The reaction mixture was PCR cycled for 18 rounds 
with a Tm of 68 ˚C. The mixture was DPN1 digested for two hours at 37 ˚C. The reaction mixture 
was plated on antibiotic resistant LB plates. Successful transformants were confirmed by gene-
sequencing.  
P450terp 
A pET-28A expression vector containing P450terp gene with a thrombin cleavable N-
terminal His-tag was ordered from GenScript. The plasmid was transformed into E. coli C41 cells. 
A 100 mL starter culture was inoculated and shaken at 180 rpm overnight at 37° C. The starter 
culture was used to inoculate 7 L of TB media and the cells were grown at 37° C at 225 rpm to an 
optical density (OD) of ≥1.0 before induction via 1 mM IPTG and supplemented with 1 mM D-
aminolevulinic acid (D-ALA). At this time, growth conditions were slowed to 80 rpm and cooled 
to 18° C. Cells were harvested after 48 hours. The cells were broken by microfluidization and 
high-speed centrifuged. The supernatant was brought to 30% ammonium sulfate and clarified by 
centrifugation. The soluble cut was brought to 40% ammonium sulfate and centrifuged. The 
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supernatant of the 40% cut was loaded onto a Nickel-NTA column. The column was washed with 
lysis buffer (50 mM KPi pH 7.4, 100 mM KCl, 5 mM βME) and protein was eluted from Ni-NTA 
column using a 0-30 mM histidine-free base. Fractions with A418/280>1.2 were collected, 
concentrated, and loaded onto DEAE column and washed with buffer. Protein was eluted from 
the column with a gradient of 0-500 mM KCl. Total protein content was calculated and a thrombin 
digest (50:1) was performed for 12 hours at 4° C and digestion was confirmed by MALDI-TOF 
mass spectrometry. After digestion, the protein was loaded back onto a Ni-NTA column and 
washed and eluted with a gradient of 0-5 mM His-free base. Fractions with A418/280>1.4 were 
combined and concentrated and purified further by size-exclusion chromatography. Protein 
concentration was determined using previously determined extinction coefficients ε418=120 mM-
1 cm-1 (substrate free) and ε396= 96 mM-1 cm-1 (substrate bound).6 
 
Figure 4-7. (A) SDS-PAGE gel of P450terp. (B) UV-vis spectrum of substrate free (black) and a-
terpineol bound (red) P450terp. 
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Crystallization of Tdx C43S: 
Tdx C43S was crystallized at a concentration of 13 mg/mL in 1.6 M Na3Citrate pH 6.5 in a 
hanging drop tray by vapor diffusion with a  protein:precipitant ratio of 1:1. Crystals of Tdx C43S 
were cryoprotected into paratone oil before flash freezing in liquid nitrogen. 
 Tdx C43S 
Data collection  
Space group P 21 21 21 
Cell dimensions  
a, b, c 30.97 80.45 86.14 
a, b, g 90, 90, 90 
Resolution (Å) 
 
37.97  - 2.15 (2.227  - 2.15) 
     Rmerge 10.6 (81.57) 
Total reflections 23412 (2110) 
     Unique reflections 11865 (1084) 
     CC1/2 0.989 (0.619) 
I/s 4.78 (0.84) 
Completeness 96.00 (89.64) 
     Redundancy 2.0 (1.9) 
Refinement  
Rwork/Rfree 0.2147 (0.3184) 
/ 0.2680 (0.3185) 
Number of atoms 1595 
Protein 1532 
Water 55 
Ligands 8 
RMSD Bond lengths (Å) 0.010 
RMSD Bond angles 1.30 
    Average B factor 33.12 
    Ramachandran 
Favored/Outliers (%) 
95.59/ 0.00 
 
 
Table 4-2. X-ray crystallography data collection and refinement statistics for Tdx-C43S 
structure. Values in parentheses are for the highest resolution shell. 
 
95 
 
 
 
 
 
 
Data Collection and Refinement 
Data were collected from single crystals at the Advanced Lightsource (ALS) beamline 
8.2.1. Diffraction images were indexed, integrated, and scaled using Mosflm.24 The 1E9M crystal 
structure without cofactor was used as a search model in molecular replacement using Phaser.25 
The final structure contains two molecules of the Tdx per asymmetric unit. The Phenix suite25 
was used for structure refinement. All reflections were used for refinement except for 5% 
excluded for Rfree calculations. The structural model was revised in real space with the program 
COOT26 based on 2Fo-Fc and Fo-Fc electron density maps. The final refinement statistics are given 
in Table 4-2. The final structure was refined to 2.15 Å resolution with an Rfree of 21.5% and Rwork of 
26.8%. 
Stopped Flow Kinetics 
 Oxygen complex formation and decay were measured using an SX.18MV stopped flow 
apparatus from Applied Photophysics at 23 °C. Briefly, ferric P450terp in buffer [50 mM 
potassium phosphate (pH 7.4) and 1 mM a-terpineol] was first degassed and purged with argon 
and then reduced inside an anaerobic cuvette and monitored on an Agilent Cary 300 UV-vis 
spectrophotometer by careful titration with a 5 mM sodium dithionite stock (in the same buffer). 
Stopped flow syringes were washed first with a 5 mM sodium dithionite solution to remove 
oxygen followed by washing with degassed and nitrogen-purged buffer 50 mM potassium 
phosphate (pH 7.4) and 1 mM a-terpineol to wash away the dithionite. First, reduced ferrous 
P450terp in 50 mM potassium phosphate (pH 7.4) and 1 mM a-terpineol was mixed with the 
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same air-saturated buffer to form the oxy complex. In the second experiment, the reduced 
ferrous P450terp was mixed with air-saturated buffer that contained a 2-fold excess of oxidized 
Tdx to compare the stability of the oxygen complex in the presence Tdx. The final concentrations 
of P450terp and Tdx after mixing in the stopped flow were around 4 and 8 μM, respectively. Data 
were fitted using Sigma Plot.  
NADH Consumption Assays 
NADH oxidation rates for P450terp enzymes were determined in steady state kinetic experiments 
using a Reductase/Ferredoxin (Flavodoxin)/P450 system in a 1:10:1 ratio, respectively. 
Experiments were performed as previously described.27 In brief, all enzymatic components were 
added at a ratio of 0.5 µM: 5 µM: 0.5 µM and mixed. 200 µM NAD(P)H was then added to the 
cuvette, mixed, and the 340 nm absorbance was monitored. This provides a background NAD(P)H 
oxidation rate. After a minute or more, substrate for the P450 was introduced, mixed, and the 
rate of NAD(P)H oxidation was measured as a function of decrease in 340 nm absorbance. 
References 
1. Sevrioukova, I. F.; Li, H.; Zhang, H.; Peterson, J. A.; Poulos, T. L., Structure of a cytochrome 
P450-redox partner electron-transfer complex. Proc. Natl. Acad. Sci. U. S. A. 1999, 96 (5), 
1863. 
2. Strushkevich, N.; MacKenzie, F.; Cherkesova, T.; Grabovec, I.; Usanov, S.; Park, H. W., 
Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. 
Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (25), 10139. 
3. Tripathi, S.; Li, H.; Poulos, T. L., Structural basis for effector control and redox partner 
recognition in cytochrome P450. Science 2013, 340 (6137), 1227. 
4. Prasad, B.; Rojubally, A.; Plettner, E., Identification of camphor oxidation and reduction 
products in Pseudomonas putida: new activity of the cytochrome P450cam system. J Chem 
Ecol 2011, 37 (6), 657-67. 
97 
 
 
 
 
 
 
5. Balaraman, P.; Plettner, E., Chemotaxis by Pseudomonas putida (ATCC 17453) towards 
camphor involves cytochrome P450cam (CYP101A1). Biochim Biophys Acta Gen Subj 2019, 
1863 (2), 304-312. 
6. Peterson, J. A.; Lu, J. Y.; Geisselsoder, J.; Graham-Lorence, S.; Carmona, C.; Witney, F.; 
Lorence, M. C., Cytochrome P-450terp. Isolation and purification of the protein and cloning 
and sequencing of its operon. Journal of Biological Chemistry 1992, 267 (20), 14193-14203. 
7. Stayton, P. S.; Sligar, S. G., Structural microheterogeneity of a tryptophan residue required 
for efficient biological electron transfer between putidaredoxin and cytochrome P-450CAM. 
Biochemistry 1991, 30 (7), 1845-1851. 
8. Hasemann, C. A.; Ravichandran, K. G.; Peterson, J. A.; Deisenhofer, J., Crystal structure and 
refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol 1994, 236 (4), 1169-85. 
9. Boddupalli, S. S.; Hasemann, C. A.; Ravichandran, K. G.; Lu, J. Y.; Goldsmith, E. J.; Deisenhofer, 
J.; Peterson, J. A., Crystallization and preliminary x-ray diffraction analysis of P450terp and 
the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the 
cytochrome P450 superfamily. Proc Natl Acad Sci U S A 1992, 89 (12), 5567-71. 
10. Sevrioukova, I. F.; Peterson, J. A., Reaction of carbon monoxide and molecular oxygen with 
P450terp (CYP108) and P450BM-3 (CYP102). Arch Biochem Biophys 1995, 317 (2), 397-404. 
11. Fruetel, J. A.; Mackman, R. L.; Peterson, J. A.; Ortiz de Montellano, P. R., Relationship of active 
site topology to substrate specificity for cytochrome P450terp (CYP108). J Biol Chem 1994, 
269 (46), 28815-21. 
12. Mo, H.; Pochapsky, S. S.; Pochapsky, T. C., A Model for the Solution Structure of Oxidized 
Terpredoxin, a Fe2S2 Ferredoxin from Pseudomonas. Biochemistry 1999, 38 (17), 5666-5675. 
13. Sevrioukova, I. F.; Garcia, C.; Li, H.; Bhaskar, B.; Poulos, T. L., Crystal structure of 
putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from 
Pseudomonas putida. J Mol Biol 2003, 333 (2), 377-92. 
14. Armengaud, J.; Sainz, G.; Jouanneau, Y.; Sieker, L. C., Crystallization and preliminary X-ray 
diffraction analysis of a [2Fe-2S] ferredoxin (FdVI) from Rhodobacter capsulatus. Acta 
Crystallogr D Biol Crystallogr 2001, 57 (Pt 2), 301-3. 
15. Morales, R.; Charon, M.-H.; Hudry-Clergeon, G.; Pétillot, Y.; Norager, S.; Medina, M.; Frey, M., 
Refined X-ray Structures of the Oxidized, at 1.3 Å, and Reduced, at 1.17 Å, [2Fe−2S] Ferredoxin 
from the Cyanobacterium Anabaena PCC7119 Show Redox-Linked Conformational Changes. 
Biochemistry 1999, 38 (48), 15764-15773. 
16. Sevrioukova, I. F., Redox-dependent Structural Reorganization in Putidaredoxin, a 
Vertebrate-type [2Fe-2S] Ferredoxin from Pseudomonas putida. Journal of Molecular Biology 
2005, 347 (3), 607-621. 
17. Lipscomb, J. D.; Sligar, S. G.; Namtvedt, M. J.; Gunsalus, I. C., Autooxidation and hydroxylation 
reactions of oxygenated cytochrome P-450cam. J. Biol. Chem. 1976, 251 (4), 1116. 
18. Unno, M.; Christian, J. F.; Benson, D. E.; Gerber, N. C.; Sligar, S. G.; Champion, P. M., 
Resonance Raman Investigations of Cytochrome P450cam Complexed with Putidaredoxin. J. 
Am. Chem. Soc. 1997, 119 (28), 6614. 
98 
 
 
 
 
 
 
19. Batabyal, D.; Lewis-Ballester, A.; Yeh, S.-R.; Poulos, T. L., A Comparative Analysis of the 
Effector Role of Redox Partner Binding in Bacterial P450s. Biochemistry 2016, 55 (47), 6517-
6523. 
20. Tyson, C. A.; Lipscomb, J. D.; Gunsalus, I. C., The Roles of Putidaredoxin and P450cam in 
Methylene Hydroxylation. Journal of Biological Chemistry 1972, 247 (18), 5777-5784. 
21. Geren, L.; Tuls, J.; O'Brien, P.; Millett, F.; Peterson, J. A., The involvement of carboxylate 
groups of putidaredoxin in the reaction with putidaredoxin reductase. Journal of Biological 
Chemistry 1986, 261 (33), 15491-5. 
22. Tsai, R. L.; Gunsalus, I. C.; Dus, K., Composition and structure of camphor hydroxylase 
components and homology between putidaredoxin and adrenodoxin. Biochemical and 
Biophysical Research Communications 1971, 45 (5), 1300-1306. 
23. Prongay, A. J.; Engelke, D. R.; Williams, C. H., Jr., Characterization of two active site mutations 
of thioredoxin reductase from Escherichia coli. J Biol Chem 1989, 264 (5), 2656-64. 
24. Battye, T. G.; Kontogiannis, L.; Johnson, O.; Powell, H. R.; Leslie, A. G., iMOSFLM: a new 
graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr., Sect. D: 
Biol. Crystallogr. 2011, 67 (4), 271. 
25. Adams, P. D.; Afonine, P. V.; Bunkoczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; 
Hung, L. W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; 
Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H., PHENIX: a 
comprehensive Python-based system for macromolecular structure solution. Acta 
Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66 (2), 213. 
26. Emsley, P.; Cowtan, K., Coot: model-building tools for molecular graphics. Acta Crystallogr., 
Sect. D: Biol. Crystallogr. 2004, 60 (12), 2126. 
27. Bell, S. G.; Dale, A.; Rees, N. H.; Wong, L. L., A cytochrome P450 class I electron transfer system 
from Novosphingobium aromaticivorans. Appl Microbiol Biotechnol 2010, 86 (1), 163-75. 
 
 
 
 
 
 
 
 
99 
 
 
 
 
 
 
Chapter 5 
CYP102L1 and the occurrence of P450s in viruses 
Introduction 
Cytochromes P450 are ubiquitous throughout the biosphere and recently their 
prevalence has been extended to life’s gray area of viruses.1-2 However, their role in viral biology 
remains unclear.  Recently, Lamb et al. reported unique P450s in megaviral genomes that inhabit 
amoeba.2 Since this report, a growing number of genes encoding for unique potential P450s in 
both giant and non-giant viruses have been annotated. In particular, one bacteriophage, 
Mycobacterium phage Adler, which infects Mycobacteroides (previously Mycobacterium) 
abscessus subsp. bolletii F1660, has a gene predicted to encode a cytochrome P450 (Genbank 
protein accession number AHB79207; genome sequence locus tag: CH35_gp012). The predicted 
471 amino acid protein defines a new CYP102 subfamily and gene, CYP102L1, within the broader 
CYP102 family. A P450 subsequently found in the mycobacterial host is 98% identical to the phage 
P450 and, therefore, it is also classified as CYP102L1 (Fig 5-2A). Additional members of the new 
CYP102L subfamily (CYP102L1-8) have now been found in other Mycobacterioides species (Fig 5-
5). The phage CYP102L1 shows lower sequence identity with genes in other CYP102 subfamilies 
(CYP102AZ). It shares only 34% identity yet retains remarkable structural similarity with the P450 
domain of CYP102A1 (P450BM3), an extensively characterized P450 (Fig 5-2B). 
 This chapter reports the structure and analysis of CYP102L1 along with the binding of 
several fatty acids and discuss the potential consequences of cytochromes P450 in viruses. 
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Figure 5-1.  Top-down (A) and side-on (B) overlay of CYP102L1 chains A (blue), C (cyan), and D 
(green). Top-down (C) and side-on (D) overlay of CYP102L1 chains A (blue), and B (yellow). Top-
down (E) and side-on (F) overlay of CYP102L1 chain B (yellow) and CYP102A1 (pale blue). 
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A 
AdlerCYP102L1      MTDTGTGVHTPQPLPHPRGRLPVLRDLLSVDFATPVQGLTREGRRHDGIFEQCIGDFRVV  60 
MACYP102L1         MTDTGTGVHTPQPLPHPRGRLPVLRDLLSVDFATPVQGLTREGRRHDGIFEQCIGDFRVV  60 
                   ************************************************************ 
 
AdlerCYP102L1      VVDGPELIEEINNPQLWEKNVGPTLHKLRSVAGDGMFTAYNSEENWRKAHEILTPAFTKE  120 
MACYP102L1         VVDGPELIEEINNPQLWEKNVGPTLHKLRSVAGDGMFTAYNSEENWRKAHEILTPAFTKE  120 
                   ************************************************************ 
 
AdlerCYP102L1      AMSTYHQRIAATVRELIDAWNTRAQNNSWIDIPAETNRLTIEIISRAGFDYQFNNLADHS  180 
MACYP102L1         AMSTYHQRIAATVRELIDAWNTRAQNNSWIDIPAETNRLTIEIISRAGFDYQFNNLADPS  180 
                   ********************************************************** * 
 
AdlerCYP102L1      ENPFITAVLRELQYANRRTDSIPFYEQFLGGRRRRLHAADKKFIRAEVDKIIDVRRINPR  240 
MACYP102L1         ENPFITAVLRELQYANRRTDSIPFYEQFLGGRRRRLHAADKKFIRAEVDKIIDVRRINPR  240 
                   ************************************************************ 
 
AdlerCYP102L1      VGQSPDMLDIMLTAADPVTGDKLDNNNIGNQILTFLVAGSETSANAIAFALHFLATTPDV  300 
MACYP102L1         VGQSPDMLDIMLTAADPVTGDKLDNNNIGNQILTFLVAGSETSANAIAFALHFLATTPDV  300 
                   ************************************************************ 
 
AdlerCYP102L1      AAQARAEVDAMWPGRTFPDFQFDQIAKLRYLRLVIDEALRLWPVAPGYFRQAKQDTTIGE  360 
MACYP102L1         AAQARAEVDAMWPGRTFPDFQFDQIAKLRYLRLVIDEALRLWPVAPGYFRQAKQDTTIGE  360 
                   ************************************************************ 
 
AdlerCYP102L1      GRYAFKKNDWVFVNLHAAHTHRSWGPDAAEFKPERMSTENRRKLGPHIYKPFGVGERACI  420 
MACYP102L1         GRYAFKKNDWVFVNLHAAHTHRSWGPDAAEFKPERMSTENRRKLGPHIYKPFGVGERACI  420 
                   ************************************************************ 
 
AdlerCYP102L1      GRQFAQHEMVIALAAILHQFELEPRPGYELKVSETLTLKPSDLQLRLRNRV           471 
MACYP102L1         GRQFAQHEMVIALAAILHQFELEPRPGYELKVSETLTLKPSDLQLRLRNRV           471 
                   *************************************************** 
B 
CYP102A1           --------MTIKEMPQPKT-FGELKNLPLLNTDKPVQALMKIADELGEIFKFEAPGRVTR 51 
CYP102L1           MTDTGTGVHTPQPLPHPRGRLPVLRDLLSVDFATPVQGLTREGRRHDGIFEQCIGDFRVV 60 
                            * : :*:*:  :  *::*  ::  .***.* : . . . **:    .  .  
 
CYP102A1           YLSSQRLIKEACDESRFDKNLSQALKFVRDFAGDGLFTSWTHEKNWKKAHNILLPSFSQQ 111 
CYP102L1           VVDGPELIEEINNPQLWEKNVGPTLHKLRSVAGDGMFTAYNSEENWRKAHEILTPAFTKE 120 
                    :.. .**:*  : . ::**:. :*: :*..****:**::. *:**:***:** *:*::: 
 
CYP102A1           AMKGYHAMMVDIAVQLVQKWERL-NADEHIEVPEDMTRLTLDTIGLCGFNYRFNSFYRDQ 170 
CYP102L1           AMSTYHQRIAATVRELIDAWNTRAQNNSWIDIPAETNRLTIEIISRAGFDYQFNNLADHS 180 
                   **. **  :.  . :*:: *:   : :. *::* : .***:: *. .**:*:**.:  .. 
 
CYP102A1           PHPFITSMVRALDEAMNKLQRANPDDPAYDE-----NKRQFQEDIKVMNDLVDKIIADRK 225 
CYP102L1           ENPFITAVLRELQYANRRTDS----IPFYEQFLGGRRRRLHAADKKFIRAEVDKIIDVRR 236 
                   :****:::* *: * .: :      * *::     .:* .  * *.:.  *****  *: 
 
CYP102A1           A--SGEQSDDLLTHMLNGKDPETGEPLDDENIRYQIITFLIAGHETTSGLLSFALYFLVK 283 
CYP102L1           INPRVGQSPDMLDIMLTAADPVTGDKLDNNNIGNQILTFLVAGSETSANAIAFALHFLAT 296 
                         ** *:*  **.. ** **: **::**  **:***:** **::. ::***:**.. 
 
CYP102A1           NPHVLQKAAEEAARVL---VDPVPSYKQVKQLKYVGMVLNEALRLWPTAPAFSLYAKEDT 340 
CYP102L1           TPDVAAQARAEVDAMWPGRTFPDFQFDQIAKLRYLRLVIDEALRLWPVAPGYFRQAKQDT 356 
                   .*.*  :*  *.  :    . *  .:.*: :*:*: :*::*******.**.:   **:** 
 
CYP102A1           VLG-GEYPLEKGDELMVLIPQLHRDKTIWGDDVEEFRPERFE--NPSAIPQHAFKPFGNG 397 
CYP102L1           TIGEGRYAFKKNDWVFVNLH-AAHTHRSWGPDAAEFKPERMSTENRRKLGPHIYKPFGVG 415 
                   .:* *.* ::*.* ::* :    : :  ** *. **:***:.  *   :  * :**** * 
 
CYP102A1           QRACIGQQFALHEATLVLGMMLKHFDFEDHTNYELDIKETLTLKPEGFVVKAKSKKIPL 456 
CYP102L1           ERACIGRQFAQHEMVIALAAILHQFELEPRPGYELKVSETLTLKPSDLQLRLRNRV--- 471 
                   :*****:*** ** .:.*. :*::*::* : .***.:.*******..: :: :.:     
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Structure and function of mycophage CYP102L1  
The protein in the open state was crystallized and the structure was determined by single-
wavelength anomalous diffraction (SAD) and was refined with a maximum resolution of 2.5 Å. 
The overall structure of the CYP102L1 exhibits the typical P450 fold consisting of α-helical and β 
sheet domains as seen in all other known archaeal, bacterial, and eukaryotic P450 structures (Fig 
5-1).1 The heme cofactor is located between the α-helical domain and the β-sheet domain to 
create a substrate-binding pocket. The CYP102L1 has a conserved cysteine (Cys419) that serves 
as the fifth axial thiolate ligand to the heme iron, as in all P450s. The structure solved is strikingly 
similar to that for the P450 domain of the Bacillus megaterium CYP102A1 (Fig 5-1E,F).  
Comparison of CYP102L1 and CYP102A1  
Despite the low sequence identity to 102A1, the structure of the two proteins is 
remarkably conserved. As backbone or Cα RMSD values only provide averaged information of the 
pairwise distances of atoms in space and are not sensitive to similarities of local geometries, the 
TMscore developed by Zhang et al. provides a more useful metric for understanding similarities 
of the global fold in a length independent manner.3-4 The TM-scoring scale is from 0 to 1, where 
a score of < 0.3 is random structural similarity and are essentially unrelated, >0.5 possess 
generally the same fold, and a score of 1 is a perfect match. In Table 5-1, each monomer of 
CYP102L1 was aligned using TM-align and compared one another and then to the substrate free 
structure of P450BM3 (1FAH).5 As a negative control, all structures are compared to a substrate 
free crystal structure of P450cam (3L62)6 demonstrating that a general P450 architecture still 
possesses significantly different TM scores than those of well-aligned structures. The alignment 
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Chain B in both CYP102L1 and 102A1 (1FAH), have the highest TM-score and lowest RMSD, 
0.94361 and 1.53 Å respectively. 
 
Some noteworthy aspects of this structure are the differences of monomer chains A, C, D 
that possess TM-scores around 0.99 and RMSDs of less than 1 Å, while chain B is the most 
dissimilar from these with a TM-score around .95 and RMSDs around 1.4 Å against the other 
monomers. However, chain B is the most structurally similar to CYP102A1. Specifically, a portion 
of the first 24 residues that are not resolvable at the N-termini of chains A, C, D is visible in chain 
B, which is missing only 9 residues from the N-terminus. The 15 visible residues begin to 
accommodate some of the beta sheet domain seen at the N-term of CYP102A1. Additionally, the 
B chain monomer has a more closed G helix than chains A, C, D by ~3 Å. This is most likely 
attributable to crystal packing, as monomer contacts occur at the F/G loops in these three chains. 
 CYP102L1-A CYP102L1-B CYP102L1-C CYP102L1-D 102A1-A 
(1FAH) 
102A1-B 
(1FAH) 
P450cam 
(3L62) 
CYP102L1-A 1.00000 
(446:0.00) 
0.94536 
(432:1.36) 
0.99195 
(446:0.72) 
0.99226 
(434:0.73) 
0.91571 
(435:2.42) 
0.91973 
(435:2.31) 
0.80318 
(375:3.38) 
CYP102L1-B  1.00000 
(448:0.00) 
0.94936 
(432:1.38) 
0.95363 
(423:1.41) 
0.93979 
(437:1.62) 
0.94361 
(437:1.53) 
0.81736 
(379:3.25) 
CYP102L1-C   1.00000 
(446:0.00) 
0.99315 
(434:0.64) 
0.91488 
(434:2.39) 
0.91963 
(434:2.23) 
0.80397 
(375:3.35) 
CYP102L1-D    1.00000 
(434:0.00) 
0.92407 
(426:2.35) 
0.92841 
(426:2.22) 
0.79078 
(370:3.41) 
102A1-A 
(1FAH) 
    1.00000 
(455:0.00) 
0.99079 
(455:0.76) 
0.82567 
(383:3.29) 
102A1-B 
(1FAH) 
     1.00000 
(455:0.00) 
0.82930 
(382:3.18) 
P450cam 
(3L62) 
      1.00000 
(400:0.00) 
Table 5-1. TM-scores of Cyp102L1 monomers aligned to each monomer within the asymmetric unit. 
1FAH - Substrate free Cyp102A1 monomers. 3L62 - Substrate free open structure of P450cam. The 
number of residues used for the alignment and RMSD (Å) are shown in parenthesis.  
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It is these crystal-packing interactions that may provide stability to the F/G loops in chains A, C, 
D, hence why their loops are more resolvable than that in chain B. 
Figure 5-3. (A) Overview of CYP102L1 with F/G helices in cyan and B/C loop in red. (B) Cacodylate (purple) 
binding site with residues within hydrogen bonding distance. 2Fo-Fc displayed in mesh at 1.5 s (blue) and 
7 s (red). 
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Figure 5-4. Spectral shift analysis of Mycobacteria phage Adler CYP102L1 (2 μM) with the fatty 
acids lauric acid (200 μM), myristic acid (50 μM), palmitic acid (50 μM). Absolute spectra are 
shown, with differential absorbance in the inset.  
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While sequence identity to 102A1 is quite low, retention of a number of resides that have 
been implicated in substrate binding affinity, turnover, and electron transfer are conserved. With 
102L1 residues in parenthesis, mutation of residues A82(92)7, I401(420)8-9 in CYP102A1 affect 
substrate binding and turnover, while F87 (97)10, T268 (282)5, 11, A328 (245)12, A330 (347)13  affect 
substrate selectivity. F261 (275)8, A264 (278)14-15, T268 (282)5, 11, and F393(412)11, 16  affect 
electron transfer through either tuning the redox potential and/or changing the ET rate. 
CYP102A1 residues that are not conserved are R47 (F57)17, L86 (M96)8, and L188 (T199)10 and, 
upon mutation of CYP102A1, affect substrate binding, redox potential and electron transfer, and 
substrate selectivity, respectively. 
Another site of interest is a cacodylate binding site in the B/C loop. Orientation of the 
cacodylate molecule is not possible at this resolution, but residues in the region provide a number 
of possible hydrogen bonding contacts such as N101, S102, and Q351. Attribution of this density 
to cacodylate comes from the strong anomalous signal of arsenic that extends to ~7 σ (Fig 5-3). 
Fatty Acid Binding 
Type I spectral shift changes were observed following the addition of the fatty acids lauric 
acid (C12), myristic acid (C14), or palmitic acid (C16) to recombinant CYP102L1, suggesting these 
fatty acids are substrates (Fig 5-4). Metabolism experiments using the exogenous CYP102A1 
reductase domain, eukaryotic POR and bacterial redox systems as electron donor proteins for 
CYP102L1 have yielded inconsistent results with palmitic acid as a potential substrate. An as yet 
undiscovered, CYP102L1 redox system may actually be necessary for phage CYP102L1 function. 
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Conversely, phage CYP102L1 may be the first CYP102 described to-date that does not function in 
fatty acid metabolism. Additional experiments are required to unravel this conundrum.  
Conclusion 
CYP102M2_Herpetosiphon_aurantiacus_DSM_785
CYP102B4_Streptomyces_scabies
CYP102J1_Burkholderia_sp
CYP102V1_Gordonia_bronchialis
CYP102F1_Actinosynnema_pretiosum_auranticum
CYP102L1_Mycobacterium_abscessus
CYP102A7_Bacillus_licheniformis
CYP102E1_Ralstonia_metallidurans_CH34
CYP102A12_Rhodopseudomonas_palustris
CYP102A9_Bacillus_weihenstephanensis
CYP102A3_Bacillus_subtilis
CYP102L3_Mycobacterium_haemophilum
CYP102G2_Saccharopolyspora_erythraea
CYP102S1_Corynebacterium_ureicelerivorans
CYP102D1_Streptomyces_avermitilis
CYP102L5_Mycobacterium_chimaera
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CYP102B1_Streptomyces_coelicolor
CYP102A11_Erythrobacter_NAP1
CYP102L7_Mycobacterium_sp
CYP102W1_Janibacter_terrae
CYP102L1_Adler_phage
CYP102A2_Bacillus_subtilis
CYP102C3_Rhodococcus_sp_R04
CYP102A15_Bacillus_pumilus
CYP102L6_Mycobacterium_chimaera
CYP102A12_Rhodopseudomonas_palustris_HaA2
CYP102Y1_Gordonia_bronchialis
CYP102N1_Nakamurella_multipartita_DSM_44233
CYP102L2_Mycobacterium_haemophilum
CYP102A14_uncultured_soil_bacterium
CYP102A13_uncultured_soil_bacterium
CYP102A10_Erythrobacter_litoralis
CYP102A4_Bacillus_anthracis_Ames
CYP102G4_Streptomyces_cattleya
CYP102A6_Bradyrhizobium_diazoefficiens
CYP102M1_Streptosporangium_roseum_DSM_43021
CYP102L4P_Mycobacterium_haemophilum
CYP102X2_Nocardia_soli
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CYP102A1_Bacillus_megaterium
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CYP102C1_Rhodococcus_sp__X309
CYP102B2_Streptomyces_avermitilis
CYP102AC1_Sinorhizobium_americanum
CYP102B3_Rhodococcus_sp_RHA1
CYP102U1_Mycobacterium
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Figure 5-5. Known CYP102 sequences in most cases are predicted from the nucleotide 
sequences. Mycobacterium phage Adler shown in red. 
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Searching all available viral genomes, we discovered a surprising number, diversity and 
distribution of P450 genes, significantly in numerous giant viruses, including genes encoding 
unique P450 proteins. We also uncovered P450 genes in a phage and a herpes virus. In animals, 
other eukaryotes, and bacteria P450 enzymes have extremely broad metabolic roles in altering 
endogenous and exogenous chemicals in synthetic and degradation pathways not thought to be 
relevant in viruses. 
The similarity of the P450 in mycobacteriophage Adler and a P450 in the Mycobacteroides 
host indicates that the phage almost certainly acquired this gene from the host. However, the 
situation is quite different in the giant viruses. P450s in giant viruses of amoebae are remarkably 
unlike any of the P450s in a common Acanthamoeba host. The P450 gene found in this 
mycobacteriophage defined a new subfamily and gene, CYP102L1. To date, only one CYP102 
protein has been examined structurally: CYP102A1 (aka P450 BM3). The crystal structure of 
phage CYP102L1 adds a second new CYP102 structure to this gene family. The CYP102L1 structure 
closely resembles that of CYP102A1 (P450 BM3), suggesting that other CYP102s might have 
retained similar structural architecture. The high degree of protein sequence identity suggests 
the phage CYP102L1 was directly derived from the host. This apparent shuttling of a P450 gene 
on a small dsDNA virus resembles the occurrence of many P450 genes found encoded in natural 
plasmids, for example the occurrence of CYP101A1 (P450cam) on a plasmid that affords the 
bacterium Pseudomonas putida the ability to utilize camphor as a sole carbon source. 
The presence of P450s in viruses leaves us with an important question. Where do the 
electrons come from? CYP102A1 possesses covalent redox partners with its FMN and FAD 
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cofactor-containing proteins attached, but CYP102l1 only seems to possess a heme domain and 
bioinformatic searches have been unsuccessful in identifying potential endogenous redox 
partners in viral genomes.  
Materials and Methods 
Mycobacteria phage Adler CYP102L1 protein expression and purification  
Protein was expressed from pET28a plasmid (Genscript) with a thrombin cleavable N-
terminal 6x-His-tag. The plasmid was transformed into C41 cells and expressed in 7 L of TB media 
shaken at 37 ˚C at 225 rpm overnight. The cells were inoculated with 1 mM IPTG and 
supplemented with 1 mM δ-ALA. The temperature was decreased to 27 ˚ C and the shaking speed 
to 130 rpm. The cells were harvested 24 hours later and re-suspended in 50 mM potassium 
Figure 5-6. SDS-PAGE gel showing the isolation of Adler phage CYP102L1. Lane 1, 
molecular-mass markers; lane 2, CYP eluate obtained. 
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phosphate pH 7.5, 500 mM NaCl, 10% (v/v) glycerol, 2 mM β-mercaptoethanol. Cells were lysed 
by sonication and cellular debris removed by centrifugation at 15,000 rpm at 4 ˚C for 60 min.  
The supernatant was loaded onto a 25 mL Ni2+-NTA agarose column and washed with 500 
mL lysis buffer containing 7 mM L-Histidine overnight. Cyp102L1 was eluted from the column 
over a gradient of 7- 100 mM L-His. The protein was buffer exchanged into 50 mM potassium 
phosphate pH 6, 20 mM NaCl, 10% (v/v) glycerol, 2 mM β-mercaptoethanol and loaded onto a 
100 mL CM-Sepharose column. The column was washed with a gradient of 500 mL 50 mM 
potassium phosphate pH 6, 20-250 mM NaCl, 10% (v/v) glycerol, 2 mM β-mercaptoethanol and 
eluted with CM buffer containing 250 to 350 mM NaCl. The protein was concentrated and buffer 
exchanged by a 25 mL Sephacryl-S200 size exclusion column into 50 mM potassium phosphate 
pH 8, 2 mM DTT. Purity of the protein was assessed by SDS-PAGE (Fig. 5-6) and UV-vis 
spectroscopy. R/Z >1.6 was used for crystallization.  
By SDS-PAGE and MALDI-TOF mass spectrometry, it was observed that thrombin cleavage 
exhibited two major products. We attributed this to a thrombin like cleavage site near the N-
term of CYP102L1’s sequence. We performed site directed mutagenesis to make the R17K 
mutant. Primers for this mutation were: F:5’-TGCCGCACCCGAATCGTCTGCCGGTT-3’ and the R: 5’-
AACCGGCAGACGATTCGGGTGCGGCA-3’. This substantially decreased the amount of the 
secondary product.  
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CYP102L1 PDB: 6N6Q 
Wavelength 1.734 
Resolution range 66.56  - 2.5 (2.589  - 2.5) 
Space group I 2 2 2 
Unit cell 119.899 174.09 203.469 
90 90 90 
Total reflections 142946 (14259) 
Unique reflections 73160 (7248) 
Multiplicity 2.0 (2.0) 
Completeness (%) 99.16 (99.49) 
Mean I/sigma(I) 7.55 (0.83) 
Wilson B-factor 62.03 
CC1/2 0.994 (0.396) 
CC* 0.998 (0.753) 
Reflections used in refinement 73117 (7241) 
Reflections used for R-free 3764 (365) 
R-work 0.2302 (0.3551) 
R-free 0.2887 (0.3921) 
CC(work) 0.938 (0.629) 
CC(free) 0.923 (0.579) 
Number of non-hydrogen 
atoms 
14644 
  macromolecules 14326 
  ligands 197 
  solvent 121 
Protein residues 1777 
RMS(bonds) 0.002 
RMS(angles) 0.51 
Ramachandran favored (%) 95.80 
Ramachandran allowed (%) 3.91 
Ramachandran outliers (%) 0.28 
Rotamer outliers (%) 1.13 
Clashscore 5.95 
Average B-factor 69.10 
  macromolecules 69.41 
  ligands 55.40 
  solvent 54.40 
Table 5-2. X-ray crystallography data collection and refinement statistics for CYP102L1 structure. 
Values in parentheses are for the highest resolution shell. 
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CYP102L1 crystallization 
Crystallization was performed using hanging drop diffusion. After initial screening and 
optimization, crystal hits were found in a condition containing 0.1 M Sodium cacodylate pH 6.5 
and 1.26 M (NH4)2SO4. Diffraction quality crystals were obtained using an additive screen that 
yielded the final condition of 0.1 M Sodium Cacodylate pH 6.5, 1.26 M (NH4)2SO4 and 4.2 % (w/v) 
Dextran Sulfate. Hanging drops were set up at with a 1:1 ratio of protein to precipitant with a 
protein concentration of 12 mg/mL.  
Data Collection and Structure Determination 
The structure of CYP102L1 was solved to a resolution of 2.5 Å by single wavelength 
anomalous diffraction at the iron K-edge (7150 eV). Images were processed, integrated, and 
scaled with the iMosflm package.18 Crystals belonged to the space group I 2 2 2, with 4 molecules 
of CYP102L1 in the asymmetric unit, where the dimensions of the unit cell were determined to 
be a=119.899 Å b= 174.09 Å c= 203.469 Å α=β=γ= 90˚. A hybrid substructure search (HySS) within 
the phenix suite of programs found 2 potential iron sites (of the 4 expected in the asymmetric 
unit). Phenix.autosol was utilized to find the remaining sites and phenix.autobuild built a partial 
model.19 The rest of the structural model was built manually in Coot and refined iteratively with 
phenix.refine.19-21 The final structure was refined to possess an Rfree = 28.8% and Rwork of 
23.0%. Crystallographic data is reported below (Table 5-2).  
CYP102L1 fatty acid spectral shifts  
Preparation and titrations of fatty acids were carried out as previously described.22 Stocks 
were 100 mM lauric acid in 50 mM K2CO3, and 10 mM myristic and palmitic acids in DMSO. 
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Experiments were performed in 1000 μL total volume at 30˚C and measurements made on an 
Agilent Cary 300 UV-vis spectrophotometer.  
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Chapter 6 
Conclusion 
Together these works highlight the complexity and importance of dynamics in the 
cytochrome P450 mechanism. As discussed in chapter one, the changes that occur in Nature’s 
aircraft carrier are to regulate and control a powerful reaction, and here we have taken a further 
step in progressing our understanding of the structure-function relationship that governs P450 
chemistry. 
 In chapter 2, we utilized molecular dynamics simulations to understand the mechanism 
of substrate binding in cytochrome P450cam. The results of these unbiased simulations revealed 
a number of surprising transitions that resulted in the prediction of a second molecule of 
camphor acting as an allosteric activator and the formation of a second active site access channel. 
The activation of P450cam by a second molecule of substrate through a distant binding pocket is 
consistent with a number of crystallographic and spectroscopic studies that extend back to the 
enzyme’s discovery. Additionally, it was the activation by the allosteric site that led to the 
formation of a new channel between the B/C loop. This channel has been suggested by biased 
molecular dynamics approaches but never observed experimentally or captured in a bias-free 
simulation and/or associated with allosteric interactions. The opening of this new channel 
presented the active site camphor with a channel for egress and is associated with a number of 
coupled mechanistic transitions that allow for the product to escape. While the allosteric site 
activation and egress channel were new findings, the limits of classical molecular dynamics left a 
number of lingering questions since after substrate binds to the active site, several critical 
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interactions take place before product egresses. These dynamic interactions include 
putidaredoxin (Pdx) binding, electron transfer, O2 binding, and hydroxylation and are the focus 
of future simulation work.  
The predictions of chapter 2 were tackled experimentally in chapter 3. The simulations 
predicted a number of changes that would presumably occur upon putidaredoxin (Pdx) binding, 
electron transfer, and/or O2 binding, and crystallization of the oxy-P450cam-Pdx complex would 
test the simulated model’s validity. However, due to the photoreduction of the complex by the 
X-ray beam and radiation-induced substrate turnover, cyanide was utilized as an O2 mimic. The 
crystal structure of the CN-P450cam-Pdx structure validated many of the subtle structural 
changes predicted by our molecular dynamics simulations, and most importantly, the formation 
of channel 2. One of the most surprising aspects of this structure was the cis-trans isomerization 
of Pro89 and Pro105, which presumably occurred within the crystal upon CN soaking. These 
changes allowed the closing of channel 1 and opening of channel 2 supporting the 
unidirectionality of substrate flow predicted in our MD study. Additionally, this structure 
corroborated an earlier NMR study that suggested that isomerization of proline residues was 
essential to the mechanism of P450cam and this is observed here for the first time 
crystallographically. 
While P450cam has served as the model system for structure-function studies of P450s, 
it is one of the most specific P450s for its redox partner, Pdx. The extension of the specificity and 
conformational regulation of P450cam to other systems is still being investigated. In chapter 4, 
we examined P450terp (CYP108A1), a homologue of P450cam, in regard to its interactions with 
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its redox partner, terpredoxin (Tdx). The crystal structure of Tdx was determined and potential 
P450terp-Tdx complex was compared to P450cam-Pdx. Tdx was also shown to exhibit a similar 
destabilization of the oxy-complex as seen in P450cam. P450terp demonstrated a less strict 
requirement for its native redox partner as it was capable of utilizing Arx as an electron donor. 
In chapter 5, we stepped outside of Class I systems to look into the structure and potential 
role of P450s in viruses. Recently, bioinformatics has revealed a number of P450s in giant and 
non-giant viruses. A new class of CYP102 was discovered to exist in both a virus and its bacterial 
host. CYP102L1 from Mycobacterium phage Adler was crystallized and shown to bind fatty acids. 
CYP102L1 showed a remarkable structural similarity to CYP102A1 despite a low sequence 
identity. However, substrate turnover assays with fatty acids failed to yield conclusive NAD(P)H 
consumption with a number of redox partners including BM3 reductase, the native electron 
transfer partner of 102A1. Further investigations are required to understand the role of viral 
P450s and find their natural redox partners.  
Future Directions and a possible P450 supercomplex  
In closing, I would like to suggest an idea and a direction for future work that the P450cam 
system forms a four- component supercomplex: PdR-Pdx-Pdx-P450cam (Fig 6-1). The idea of a 
supercomplex would be an adjustment from the traditional shuttling mechanism in Fig 1-7 and 
Fig 1-8. Support for this prediction of a supercomplex, like the motivation for chapters 2 and 3, 
stems from a reexamination of a number of experimental results. 
First, let’s look at how NADH consumption assays are performed. They are always 
performed with an excess of ferredoxin, are substrate dependent, and P450cam is nearly 100% 
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coupled.1-2  As NADH, PdR, and excess Pdx are all present prior to substrate introduction and 
reduced Pdx rapidly autoxidizes, the system should not be as tightly coupled. This implies some 
sort of communication between the reductase and the P450. PdR should be able to transfer 
electrons to the excess Pdx and prime them for ET to P450cam. 
Second, a number of studies examining the electron transfer between PdR-Pdx find the 
semiquinone intermediate formed after a one electron transfers to Pdx is either highly unstable 
or undetectable.3-6 However, this is difficult to reconcile under the standard shuttling model as 
Fe2S2-ferredoxins are only capable of undergoing one electron redox chemistry. In vitro 
measurements of steady state and kinetic properties have traditionally used terminal one-
electron acceptors such as cytochrome c or ferricyanide limiting the interpretability of the second 
Figure 6-1. Potential supercomplex of PdR-Pdx-Pdx-P450cam. Model was generated by aligning Pdx of 
PdR-Pdx (3LB8) to a monomer of a dimer within the asymmetric unit of Pdx (1XLQ) and the P450-Pdx 
complex (4JWU) to the other monomer. FAD – green. W106 – magenta. Pdx – orange. Heme – pink. 
F/G helices – cyan. B/C loop – red. 
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ET event as PdR needs to provide both electrons to the P450 and the semiquinone intermediate 
is especially unstable. Related to this is the effect of nucleotide binding on the ET rate of PdR to 
Pdx as binding of NAD+ strongly influences the PdR’s redox potential and thus increases the rate 
by orders of magnitude.5-6 It is known that Apoptosis Reducing Factor, a bifunctional 
mitochondrial flavoprotein that plays an important role in energy metabolism undergoes an 
NADH induced dimerization.7 It is possible that NADH binding to PdR induces a similar complex 
formation that is then capable of substrate dependent ET.  
The third piece of evidence is the oligomerization of Pdx. As discussed in chapter 4, one 
obstacle to the crystallization of Pdx was the non-ligating cysteines forming intermolecular 
disulfide bonds.8 The activity of these mutants was measured and a marked decrease turnover 
rate is observed. It is possible that these oligomers form in vivo and facilitate the complex 
formation and these non-ligating cysteines may be involved in electron transfer.  
Fourth is the interfaces of Pdx–PdR and Pdx–P450cam. In these two complexes, Pdx 
presents the same interface to Pdr and P450cam, which supports the shuttling mechanism of the 
ferredoxin.9-10 However, if we look at these results all together, one can imagine that if Pdx 
dimerizes, then Pdx can present the same interface to both PdR and P450cam. Additionally, if a 
complex forms, then PdR can transfer two electrons derived from the hydride to the two 
ferredoxins and with communication from the P450 so it can perform in a substrate dependent 
manner.  
Supporting this is idea of a four component or oligomeric complex is the fifth and final 
piece of evidence. One of the initial studies by Lipscomb11 found the formation of half of an 
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equivalent of product after incubation of the oxy complex with oxidized Pdx. Normally, the 
oxycomplex would require one more electron to drive turnover and oxidized Pdx should not drive 
this chemistry. These results are from the same oxycomplex decay experiment described in 
chapter 4, but the formation of product result was unexplainable. However, these stopped-flow 
experiments were done with wt-Pdx, which oligomerizes and then is mixed with oxy-P450cam. 
Pdx presents the same interface to PdR and P450cam. If Pdx forms a dimer and naturally forms 
the complex, then P450cam-Pdx-Pdx-P450cam complex is possible, which allows for back 
electron transfer from one oxy-P450, directly to the other, releasing O2 in one P450 unit and 
forming product in the other. Turnover and release of O2 returns both molecules of P450cam 
back to ferric high-spin in the presence of excess substrate, one through uncoupling and one 
through productive turnover. 
Formation of a supercomplex would prevent the need for dissociation and supports rapid 
turnover. Looking to nature, we can find many similar examples of this type of co-factor 
alignment (especially when O2 is involved) in systems like nitrate reductase or the respiratory 
complexes. (Fig 6-2).12-14 
Whatever the case may be, cytochromes P450 are one of the most complex and fasinating 
aspects of nature with much left to discover. The efforts to understand cytochrome P450 are 
highly interdisciplinary in the truest sense and the field is filled with a rich past and a bright future.  
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Appendix A 
 
Comparison of in vitro rates to in vivo requirements for P450cam 
The use of glucose vs camphor as a carbon source to produce acetyl-CoA are quite 
different net reactions. Utilizing a molecule of glucose, 2 molecules acetyl-CoA are produced and 
during their production is the net gain of 2 NADH and 2 ATP. While in the case of camphor, a net 
loss of a molecule of NADH and NADPH to produce only one molecule of acetyl-CoA and 
isobutyryl-CoA.1 
The question I posed to myself was, how much camphor would it take to power a cell for 
an hour? And can the in vitro rates we measure sustain this level of consumption?  
I need to first clarify that most of the numbers utilized below come from E.coli as it is the 
most well-documented systems for bacterial growth and metabolic function. First, what is the 
power consumption of a bacterial cell? This is a challenging question and the definition of this is 
dependent on how you measure power. The most useful definition for our purposes a 
measurable quantity is the O2 consumption by the cell. With glucose, the oxygen uptake rate of 
E.coli was 30 mmol/g (CDW)/ hour where CDW is cell dry weight.2 And per molecule of O2, 3-5 
molecules of ATP are produced or about 100mM ATP/g(CDW)/hour.3-5 Assuming a single 
bacterial cell weighs about 1x10-12 g,6 then this translates to ~109 ATP/s/cell or ~1010-1011 
ATP/hour/cell. 
Ok, now we have an idea of power consumption by a bacterial cell. Can P450cam support 
this ATP requirement? One assumption here is that camphor hydroxylation is the rate 
determining step of ATP production. About 30 molecules of ATP can be produced from a 
124 
 
 
 
 
 
 
molecule of glucose.7 However, we only get one molecule of acetyl-CoA per camphor,1 which 
cuts ATP production in half to ~15 ATP per camphor. NADH consumption in a perfectly coupled 
P450cam system is 1:1 with product formation, so we can estimate that per NADH, 15 ATP are 
produced.  The fastest reported rates for turnover rates by P450cam are ~2400 nmol/min/nmol 
of P4508 or 36000 nmol ATP/min/nm P450. Or ~3.6 x 1017 ATP/hour/6x1014 molecules of P450.  
Now the question is, how much protein is in a bacterial cell? It is estimated that there are 
between 3-4 x 106 proteins/µm3 of bacterial cell.9 So, we can ask, on average, what is the volume 
of a Pseudomonad? With a size of 1-5 µm long and 0.5 to 1 µm wide, a small cell would be on the 
order of 1 µm3.10 
If a cell contained 3.6 x 106 proteins in a 1 µm3 cell and we assume that EVERY SINGLE 
PROTEIN in the cell was a P450, then 3.6 x 109 ATP are produced per hour. Within an order of 
magnitude, this could meet the requirement of ~1010-1011 ATP/hour/cell. However, this assumes 
that EVERY SINGLE PROTEIN in the cell is a P450 and camphor hydroxylation is the rate 
determining step. P450cam alone requires 2 additional component proteins to function and this 
calculation doesn’t include the downstream proteins that would be required to turn 
hydroxycamphor to acetyl-CoA and ATP. 
While this estimate is entirely crude, it illustrated to me that there were worthwhile 
mechanistic issues worth revisiting in P450cam. Additionally, it began to chang the way I think 
about biology in vitro vs in vivo and keeping the biological context in mind when thinking about 
our chemistry (e.g. demands for survival about rates and function and efficiency). 
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